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The	  proteasome	  is	  responsible	  for	  breaking	  down	  the	  majority	  of	  the	  proteins	  in	  
the	  cell.	  	  However,	  a	  complete	  understanding	  of	  how	  this	  large	  multi-­‐subunit	  protease	  is	  
assembled	  is	  currently	  lacking.	  	  Proper	  and	  timely	  assembly	  of	  the	  proteasome	  is	  critical	  
for	  the	  functioning	  of	  the	  ubiquitin-­‐proteasome	  pathway,	  defects	  in	  which	  have	  been	  
associated	  with	  several	  different	  cancers.	  	  	  A	  recently	  discovered	  heterodimeric	  
proteasome	  assembly	  chaperone,	  Pba1p-­‐Pba2p,	  has	  been	  suggested	  to	  prevent	  the	  
assembly	  process	  from	  straying	  off	  path.	  	  Pba1p-­‐Pba2p	  associates	  with	  proteasomal	  
assembly	  intermediates	  via	  C-­‐terminal	  HbYX	  motifs.	  	  The	  HbYX	  motif	  is	  a	  tri-­‐peptide	  
sequence	  containing	  a	  hydrophobic	  residue	  (Hb)	  followed	  by	  a	  tyrosine	  (Y),	  then	  any	  
amino	  acid	  (X).	  	  This	  motif	  was	  originally	  identified	  in	  proteasomal	  activators,	  and	  shown	  
to	  mediate	  the	  association	  of	  activators	  with	  the	  proteasome	  by	  inserting	  into	  
intersubunit	  pockets	  on	  either	  end	  of	  the	  proteasome.	  	  There	  are	  seven	  unique	  
intersubunit	  binding	  pockets,	  located	  between	  neighboring	  α	  subunits	  on	  the	  
proteasome,	  to	  which	  a	  HbYX-­‐containing	  protein	  can	  bind;	  which	  of	  these	  pockets	  




bind	  via	  a	  crosslinking	  approach.	  	  Specific	  residues	  were	  mutagenized	  to	  cysteines	  on	  
Pba1p,	  Pba2p,	  and	  the	  individual	  α	  subunits	  in	  order	  to	  generate	  crosslinkable	  species.	  	  
By	  exposing	  yeast	  cells	  expressing	  these	  crosslinkable	  proteins	  to	  mild	  oxidizing	  
conditions,	  I	  attempted	  to	  trap	  the	  Pba1p	  and	  Pba2p	  α	  intersubunit	  pocket	  interactions.	  	  
In	  order	  to	  optimize	  crosslinking	  conditions,	  the	  assay	  was	  modified	  several	  ways.	  	  
Additionally,	  measures	  were	  taken	  to	  increase	  detection	  of	  the	  crosslinked	  species	  via	  
immunoblotting.	  	  Despite	  the	  efforts	  to	  improve	  the	  crosslinking	  and	  detection,	  I	  was	  
unable	  to	  successfully	  detect	  a	  crosslinked	  species.	  	  However,	  crosslinking	  is	  a	  
reasonable	  method	  to	  identify	  the	  Pba1p	  and	  Pba2p	  proteasomal	  binding	  sites,	  having	  
been	  successfully	  used	  to	  identify	  binding	  sites	  for	  other	  HbYX-­‐motif-­‐containing	  proteins;	  





CHAPTER	  1. INTRODUCTION	  
1.1 Introduction	  
	   Orlowski	  and	  Wilk	  in	  the	  early	  1980’s	  were	  the	  first	  to	  describe	  a	  high	  molecular	  
weight	  ‘multicatalytic	  protease	  complex’	  (Wilk	  &	  Orlowski,	  1983)	  which	  is	  now	  known	  to	  
be	  the	  proteasome.	  	  Shortly	  after	  the	  purification	  of	  these	  ‘multicatalytic	  protease	  
complexes,’	  several	  others	  described	  the	  same	  complex	  in	  different	  eukaryotic	  cells,	  and	  
with	  each	  new	  discovery	  came	  a	  new	  name	  such	  as	  ‘prosome’	  (Schmid	  et	  al,	  1984),	  	  
‘ingensin’	  (Ishiura	  &	  Sugita,	  1986),	  ‘macropain’	  (McGuire	  &	  DeMartino,	  1986),	  and	  ‘20S	  
protease’	  (Hough	  et	  al,	  1987).	  	  By	  the	  late	  1980’s,	  prosomes	  and	  the	  other	  protease	  
complexes	  were	  shown	  to	  be	  nearly	  identical	  in	  terms	  of	  structure	  and	  at	  least	  similar	  in	  
function.	  	  Eventually,	  the	  multicatalytic	  protease	  complex,	  prosomes,	  ingensin,	  
macropain,	  and	  20S	  protease	  would	  be	  referred	  to	  as	  the	  20S	  proteasome	  (Arrigo	  et	  al,	  
1988).	  
	   When	  Rechsteiner	  and	  colleagues	  described	  the	  20S	  protease	  in	  rabbit	  
reticulocytes,	  they	  also	  characterized	  an	  additional	  protease.	  	  This	  protease	  was	  a	  multi-­‐
subunit	  ATP-­‐dependent	  protease	  at	  a	  high	  molecular	  weight	  (Hough	  et	  al,	  1987).	  	  This	  




Further	  characterization	  of	  this	  complex	  demonstrated	  that	  this	  protease	  was	  
responsible	  for	  degrading	  ubiquitin	  tagged	  proteins	  within	  the	  cell	  (Eytan	  et	  al,	  1989).	  
1.2 Proteasome-­‐Ubiquitin	  Pathway	  
	   The	  26S	  proteasome	  is	  the	  degradation	  component	  of	  the	  ubiquitin-­‐proteasome	  
pathway.	  	  This	  pathway	  is	  responsible	  for	  selectively	  degrading	  the	  majority	  of	  soluble	  
proteins	  within	  the	  cell.	  	  There	  are	  other	  systems/organelles	  within	  the	  cell	  that	  perform	  
degradative	  processes,	  such	  as	  lysosomes.	  	  However,	  the	  degradation	  that	  occurs	  in	  
lysosomes,	  unlike	  the	  proteasome,	  is	  non-­‐specific.	  	  Having	  a	  highly	  specific	  degradation	  
system	  is	  advantageous	  in	  living	  systems	  that	  have	  highly	  regulated	  mechanisms	  such	  as	  
the	  cell	  cycle,	  metabolism,	  and	  embryogenesis	  (reviewed	  by	  Hochstrasser,	  1995).	  	  
	   One	  of	  the	  early	  steps	  in	  the	  degradation	  of	  a	  protein	  by	  the	  ubiquitin-­‐
proteasome	  pathway	  involves	  the	  modification	  of	  this	  protein	  via	  the	  covalent	  
attachment	  of	  ubiquitin.	  	  A	  single	  ubiquitin	  protein	  is	  roughly	  8	  kDa,	  and	  it	  is	  usually	  
linked	  to	  proteins	  via	  an	  isopeptide	  bond	  between	  the	  carboxyl-­‐terminus	  of	  the	  
ubiquitin	  and	  a	  lysine	  of	  the	  target	  protein.	  However,	  other	  linkages,	  such	  as	  the	  N-­‐
terminus	  of	  a	  protein,	  are	  also	  possible	  (Breitschopf	  et	  al,	  1998).	  	  Ubiquitination	  is	  
carried	  out	  by	  three	  enzymes:	  E1,	  E2,	  and	  E3	  (Figure	  1).	  	  E1,	  also	  known	  as	  the	  ubiquitin-­‐
activating	  enzyme,	  is	  responsible	  for	  adenylating	  the	  ubiquitin,	  creating	  a	  ternary	  
intermediate	  complex	  that	  is	  then	  attacked	  by	  the	  sulfhydyl	  group	  of	  the	  enzyme,	  
leading	  to	  the	  E1-­‐ubiquitin	  thioester.	  	  A	  tranesterification	  reaction	  then	  occurs	  whereby	  
the	  covalently-­‐bound	  ubiquitin	  is	  transferred	  to	  a	  cysteine	  residue	  of	  an	  E2	  enzyme	  (also	  




(ubiquitin-­‐ligase),	  will	  then	  catalyze	  the	  addition	  of	  that	  activated	  ubiquitin	  to	  a	  
substrate.	  	  Once	  a	  protein	  is	  monoubiquinated,	  it	  may	  go	  through	  several	  rounds	  of	  
ubiquitination	  (reviewed	  by	  Hochstrasser,	  1996).	  	  
	   Polyubiquitination	  occurs	  when	  the	  C-­‐terminus	  of	  an	  incoming	  ubiquitin	  protein	  
is	  attached	  to	  one	  of	  the	  seven	  lysine	  residues	  on	  a	  ubiquitin	  already	  attached	  to	  a	  
substrate	  (Xu	  et	  al,	  2009).	  	  Depending	  on	  which	  lysine	  residue	  the	  new	  ubiquitin	  
attaches	  to	  can	  determine	  if	  the	  protein	  will	  be	  targeted	  for	  proteolysis	  or	  a	  non-­‐
proteolytic	  process,	  such	  as	  cell	  signaling.	  	  As	  for	  proteolysis,	  certain	  lysine	  linkages	  will	  
target	  a	  substrate	  directly	  to	  the	  26S	  proteasome	  for	  degradation,	  while	  other	  linkages	  
will	  target	  a	  substrate	  to	  ERAD	  (Endoplasmic	  Reticulum	  Associated	  Degradation),	  which	  
eventually	  leads	  to	  destruction	  by	  the	  26S.	  	  It	  was	  determined	  that	  all	  lysine	  linkages,	  
except	  those	  utilizing	  K63,	  can	  lead	  to	  proteasomeal	  degradation.	  	  K63	  linkages	  have	  
been	  implicated	  in	  non-­‐proteaolytic	  pathways	  such	  as	  cell	  signaling	  and	  intracellular	  
trafficking	  (reviewed	  by	  Welchman	  et	  al,	  2005).	  	  K48	  and	  to	  some	  extent	  K11	  are	  the	  
most	  relevant	  linkages	  for	  proteasome	  degradation.	  	  K48	  linkages	  lead	  to	  26S	  
degradation	  (van	  Nocker	  &	  Vierstra,	  1993),	  and	  K11	  linkages	  have	  been	  implicated	  in	  
ERAD	  (Endoplasmic	  Reticulum	  Associated	  Degradation)	  (Xu	  et	  al,	  2009),	  which	  ends	  with	  
destruction	  by	  the	  26S	  proteasome.	  	  In	  addition	  to	  being	  polyubiquinated,	  a	  
monoubiquinated	  protein	  may	  be	  deubiquitinated	  by	  a	  deubiquitinaing	  enzyme	  (DUBs),	  
(reviewed	  by	  Hochstrasser,	  1995).	  	  DUBs	  are	  also	  necessary	  to	  remove	  polyubiquitin	  




1.3 26S	  Structure	  
	   The	  structure	  of	  the	  26S	  proteasome	  consists	  of	  a	  20S	  core	  particle	  (CP)	  capped	  
on	  one	  or	  both	  ends	  by	  the	  19S	  regulatory	  particle	  (RP)	  (DeMartino	  &	  Slaughter,	  1999).	  	  
The	  double-­‐capped	  structure	  is	  approximately	  2.59	  MDa,	  while	  the	  single-­‐capped	  CP	  is	  
around	  1.66	  MDa	  (Saeki	  &	  Tanaka,	  2012).	  
	  
1.3.1 20S	  Structure	  
In	  eukaryotes,	  the	  20S	  CP	  is	  made	  up	  of	  14	  different	  subunits,	  which	  are	  encoded	  
by	  14	  different	  genes	  (Chen	  &	  Hochstrasser,	  1995).	  	  These	  genes	  encode	  seven	  distinct	  
α	  and	  β	  subunits.	  	  The	  α	  and	  β	  subunits	  assemble	  into	  four	  stacked	  hetero-­‐heptameric	  
rings:	  α(1-­‐7)β(1-­‐7)β(1-­‐7)α	  (1-­‐7).	  	  Three	  of	  the	  seven	  β	  subunits	  (β1,	  β2,	  and	  β5)	  contain	  
propeptides	  that	  are	  cleaved	  upon	  20S	  CP	  assembly,	  exposing	  a	  catalytically	  active	  
threonine	  residue	  (Thr1)	  (Groll	  et	  al,	  1997).	  	  The	  rings	  form	  a	  barrel-­‐like	  structure	  that	  
has	  an	  approximate	  molecular	  mass	  of	  730	  kDa.	  	  The	  central	  chamber	  of	  this	  structure	  is	  
where	  the	  catalytically	  active	  threonine	  residues	  are	  exposed.	  	  This	  chamber	  is	  gated	  on	  
both	  ends	  of	  the	  20S	  CP	  by	  the	  α	  subunit	  N-­‐terminal	  tails,	  which	  can	  be	  opened	  by	  
activator	  proteins,	  such	  as	  the	  19S	  RP	  (Groll	  et	  al,	  1997).	  
1.3.2 19S	  Structure	  
	   The	  RP	  (also	  known	  as	  PA700)	  is	  made	  up	  of	  about	  20	  subunits	  with	  a	  molecular	  
mass	  of	  930	  kDa.	  	  The	  RP	  is	  comprised	  of	  two	  types	  of	  subunits,	  Rpt	  (Regulatory	  Particle	  




assemble	  into	  two	  major	  sub-­‐complexes:	  a	  base	  and	  a	  lid.	  	  The	  base	  is	  composed	  of	  a	  
hexameric	  ring	  of	  Rpt	  subunits	  and	  three	  Rpn	  subunits,	  and	  the	  lid	  is	  composed	  of	  nine	  
Rpn	  subunits	  (Glickman	  et	  al,	  1998).	  	  	  
	   Historically,	  the	  hexameric	  Rpt	  ring	  in	  the	  base	  was	  thought	  to	  be	  a	  flat	  ring	  
where	  the	  C-­‐termini	  of	  the	  Rpts	  inserted	  into	  the	  intersubunit	  pockets	  of	  the	  20S	  α-­‐ring	  
(see	  below).	  	  Recent	  work	  has	  demonstrated	  that	  the	  C-­‐termini	  do	  in	  fact	  bind	  to	  the	  α-­‐
ring	  intersubunit	  pockets	  asymmetrically	  (Tian	  et	  al,	  2011).	  	  Moreover,	  the	  lid	  was	  
thought	  to	  be	  associated	  exclusively	  with	  the	  base	  component.	  	  Lander	  et	  al	  (2012),	  
Lasker	  et	  al	  (2012),	  and	  DeFonesca	  et	  al	  (2012)	  have	  all	  recently	  published	  new	  electron	  
microscopy	  findings	  that	  suggest	  the	  19S	  subunits	  are	  not	  exactly	  arranged	  as	  previously	  
thought.	  	  These	  results	  have	  shown	  that	  the	  lid	  interacts	  with	  the	  base	  as	  well	  at	  the	  20	  
CP,	  and	  the	  Rpt	  subunits	  are	  not	  arranged	  in	  a	  flat	  ring	  but	  in	  a	  spiral	  staircase	  (Lander	  et	  
al,	  2012).	  	  These	  new	  images	  of	  the	  19S	  and	  the	  26S	  are	  changing	  the	  way	  the	  field	  
views	  the	  19S	  regulatory	  particle.	  
1.3.3 Archaeal	  and	  Eubacterial	  20S	  Proteasomes	  
	   20S	  proteasomes	  have	  been	  identified	  in	  both	  eubacteria	  and	  archaea.	  	  Even	  
though	  the	  first	  proteasomes	  were	  identified	  in	  eukaryotes,	  the	  prokaryotic	  versions	  
have	  been	  used	  to	  more	  easily	  study	  the	  complex	  eukaryotic	  species	  (Volker	  &	  Lupas,	  
2002).	  	  The	  archaeal	  version	  of	  the	  20S	  proteasome	  consists	  of	  one	  type	  of	  α	  and	  one	  
type	  of	  β	  subunit	  that	  form	  four-­‐homoheptameric	  rings:	  α7β7β7α7.	  	  The	  first	  eubacterial	  




different	  α	  subunits	  and	  two	  different	  β	  subunits	  that	  assemble	  into	  four	  hexameric	  
stacked	  rings	  (Tamura	  et	  al,	  1995).	  
	  
1.4 20S	  Proteasome	  Assembly	  
	   The	  current	  picture	  of	  the	  assembly	  process	  begins	  with	  α-­‐ring	  formation,	  with	  
each	  α-­‐ring	  acting	  as	  a	  scaffold	  for	  β	  subunits	  (Hirano	  et	  al,	  2005).	  	  The	  β	  subunits	  are	  
incorporated	  onto	  the	  α-­‐ring	  in	  the	  following	  order:	  β2,	  β3,	  β4,	  β5,	  β6,	  β1,	  and	  β7	  
(Hirano	  et	  al,	  2008).	  	  Subunits	  β1,	  β2,	  and	  β5	  are	  synthesized	  with	  propeptides.	  During	  
β-­‐ring	  formation	  in	  yeast,	  at	  least	  three	  different	  proteasomal	  intermediates	  have	  been	  
characterized:	  the	  15S	  complex,	  -­‐β7	  half-­‐mer,	  and	  the	  half-­‐proteasome	  (Figure	  2).	  	  The	  
15S	  complex	  contains	  one	  α-­‐ring	  with	  β2,	  β3,	  and	  β4.	  	  The	  -­‐	  β7	  half-­‐mer	  consists	  of	  a	  α-­‐
ring	  plus	  all	  of	  the	  β	  subunits,	  except	  β7,	  and	  the	  half-­‐proteasome	  consists	  of	  one	  full	  α-­‐
ring	  and	  one	  full	  β-­‐ring.	  	  After	  they	  are	  formed,	  the	  two	  half	  proteasomes	  will	  quickly	  
dimerize,	  forming	  four	  stacked	  rings	  (Li	  et	  al,	  2007).	  	  At	  this	  point,	  the	  propeptides	  are	  
still	  present	  on	  the	  β	  subunits,	  and	  the	  structure	  can	  be	  referred	  to	  as	  the	  “pre-­‐holo	  
proteasome,”	  or	  PHP.	  	  Following	  half-­‐proteasome	  dimerization	  to	  give	  rise	  to	  the	  PHP,	  
the	  propeptides	  on	  β1,	  β2,	  and	  β5	  are	  cleaved,	  exposing	  a	  threonine	  residue	  (Thr1),	  
leaving	  three	  distinct	  catalytic	  activities:	  peptidyl-­‐glutamyl	  peptide	  hydrolyzing	  activity	  
(β1),	  trypsin-­‐like	  activity	  (β2),	  and	  the	  chymotrypsin-­‐like	  activity	  (β5).	  	  Therefore	  β	  
subunits	  1,	  2,	  and	  5	  are	  responsible	  for	  cleaving	  after	  acidic,	  basic,	  and	  hydrophobic	  




subunits	  is	  necessary	  for	  autocatalytic	  (i.e.	  self-­‐processing	  of	  the	  propeptides)	  and	  
proteolytic	  function	  (Heinemeyer	  et	  al,	  1997).	  	  All	  of	  the	  20S	  subunits	  are	  essential	  for	  
assembly	  in	  yeast,	  with	  the	  exception	  of	  α3.	  	  When	  α3	  is	  deleted,	  a	  second	  copy	  of	  α4	  
takes	  its	  place	  (Velichutina	  et	  al,	  2004).	  	  These	  α3Δ	  mutant	  proteasomes	  were	  shown	  to	  
grow	  better	  than	  wild-­‐type	  proteasomes	  in	  the	  presence	  of	  heavy	  metals	  (Kusmierczyk	  
et	  al,	  2008).	  
	   Once	  the	  CP	  is	  fully	  formed,	  the	  α	  subunit	  N-­‐terminal	  tails	  act	  as	  a	  gate	  to	  the	  
catalytic	  chamber,	  which	  measures	  13	  Å	  across.	  	  The	  chamber	  may	  be	  opened	  artificially	  
with	  0.02%	  SDS	  (Smith	  et	  al,	  2007);	  however,	  in	  vivo	  it	  is	  opened	  by	  activators	  from	  
three	  different	  families:	  (a)	  the	  conserved	  Blm10/PA200	  proteins	  found	  in	  all	  eukaryotes;	  
(b)	  the	  PA28/11S	  protein	  family,	  with	  PA28αβ	  hetero-­‐heptamers	  and	  the	  homo-­‐
heptameric	  PA28γ	  present	  in	  higher	  eukaryotes;	  and	  (c)	  complexes	  composed	  of	  or	  
containing	  AAA+	  ATPases,	  like	  the	  19S	  regulatory	  particle	  (Schmidt	  et	  al,	  2011).	  	  
	  
1.4.1	   Archaeal	  and	  Eubacterial	  20S	  Assembly	  
	   As	  previously	  mentioned,	  the	  archaeal	  version	  of	  the	  20S	  proteasome	  consists	  of	  
one	  type	  of	  α	  and	  one	  type	  of	  β	  subunit.	  	  When	  these	  subunits	  are	  expressed	  
recombinantly	  in	  E.coli	  the	  α	  and	  β	  subunits	  will	  self-­‐assemble	  into	  fully	  active	  20S	  
proteasomes	  indistinguishable	  from	  their	  natively	  purified	  counterparts.	  	  If	  only	  α	  
subunits	  are	  expressed,	  these	  subunits	  will	  self	  assemble	  into	  single	  and	  double	  




detected	  (Zwickl	  et	  al,	  1994).	  	  Taken	  together,	  these	  data	  corroborate	  the	  currently	  
accepted	  model	  of	  α	  rings	  serving	  as	  templates	  for	  β	  subunit	  assembly.	  	  However,	  to	  
date,	  there	  are	  no	  studies	  indicating	  the	  in	  vivo	  assembly	  process	  for	  archaeal	  
proteasomes.	  	  The	  assembly	  process	  could	  start	  with	  α/α	  homodimer	  or	  an	  α/β	  
heterodimer	  (Heinemeyer	  et	  al,	  2004).	  
	   Similar	  to	  the	  archaeal	  proteasomes,	  when	  eubacterial	  proteasomal	  subunits	  are	  
expressed	  in	  E.coli,	  functional	  proteasomes	  will	  self-­‐assemble.	  	  However,	  unlike	  the	  
archaeal	  system,	  α-­‐rings	  are	  not	  observed	  in	  E.coli	  reconstitution.	  	  Ring	  structures	  are	  
only	  formed	  when	  both	  the	  α	  and	  β	  subunits	  are	  expressed.	  These	  subunits	  assemble	  
into	  half-­‐proteasomes	  consisting	  of	  one	  heptameric	  α-­‐ring	  adjoined	  to	  a	  heptameric	  
unprocessed	  β-­‐ring.	  	  When	  two	  half-­‐proteasomes	  dimerize,	  the	  β	  subunits	  are	  
processed	  (Zuhl	  et	  al,	  1997).	  	  Since	  α	  and	  β	  subunits	  need	  to	  be	  present	  to	  form	  ring	  
structures,	  this	  suggests	  that	  in	  bacterial	  20S	  proteasomes	  α-­‐β	  heterodimers	  form	  first,	  
as	  opposed	  to	  α	  rings	  forming	  and	  acting	  as	  a	  scaffold	  for	  the	  entry	  of	  β	  subunits.	  
	  
1.5 Alternate	  Eukaryotic	  20S	  Proteasomes	  
	   Within	  higher	  eukaryotes,	  at	  least	  three	  alternative	  proteasomes	  have	  been	  







1.5.1	   Immunoproteasome	  
	   The	  immunoproteasome	  is	  a	  protease,	  which	  is	  responsible	  for	  processing	  of	  
antigens	  for	  presentation	  by	  the	  major	  histocompatibility	  complex	  (MHC)	  class	  I	  
molecules.	  	  In	  many	  ways	  it	  is	  structurally	  similar	  to	  the	  20S	  CP;	  however,	  the	  
catalytically	  active	  β1,	  β2,	  and	  β5	  subunits	  are	  replaced	  with	  alternative	  catalytically	  
active	  subunits	  LMP2	  (low	  molecular	  weight	  protein),	  LMP7	  (Tanaka,	  1994),	  and	  MECL1	  
(mulitcatyltic	  endopeptidase	  complex-­‐like)	  (Groettrup	  et	  al,	  1997).	  	  In	  the	  presence	  of	  
interferon-­‐γ,	  LMP2	  (also	  called	  β1i),	  MECL1	  (β2i),	  and	  LMP7	  (β5i)	  are	  induced	  and	  
replace	  β1,	  β2,	  and	  β5	  subunits	  in	  the	  20S	  CP,	  creating	  new	  complexes.	  	  In	  addition	  to	  
the	  induction	  of	  βi	  subunits,	  a	  special	  activator	  is	  also	  induced,	  the	  11S,	  also	  known	  as	  
PA28	  (Knowlton	  et	  al,	  1997).	  	  (See	  activators)	  
1.5.2	   Thymoproteasome	  
	   Another	  alternative	  proteasome	  found	  within	  mammals	  is	  the	  thymoproteasome.	  	  
It	  is	  very	  similar	  to	  the	  immunoproteasome	  in	  that	  it	  contains	  β1i	  and	  β2i;	  however,	  its	  
replacement	  for	  the	  β5	  subunit	  is	  not	  β5i	  (LMP7)	  but	  β5t.	  	  Thymoproteasomes	  are	  
exclusively	  found	  in	  cortical	  thymic	  epithelium	  and	  are	  necessary	  for	  efficient	  
maturation	  of	  competent	  CD8+T	  cells	  (Murata	  et	  al,	  2007).	  	  	  
1.5.3	   Testes-­‐Specific	  Proteasome	  
	   The	  third	  alternative	  proteasome	  found	  within	  the	  eukaryotic	  kingdom	  is	  the	  
testes	  specific	  proteasome.	  	  A	  study	  in	  Drosophila	  melanogaster	  demonstrated	  that	  




Belote,	  2007).	  	  Zhong	  and	  colleges	  sought	  out	  to	  characterize	  one	  of	  the	  testes-­‐specific	  
proteasome	  subunits,	  Prosα6T.	  	  Knockout	  studies	  of	  this	  specific	  subunit	  demonstrated	  
a	  problem	  with	  post-­‐meiotic	  sperm	  cell	  differentiation.	  Therefore,	  testes-­‐specific	  
proteasome	  subunit	  Prosα6T	  has	  a	  functional	  role	  in	  normal	  spermatogenesis	  (Zhong	  &	  
Belote,	  2007).	  	  The	  function	  of	  the	  other	  testes-­‐specific	  subunits	  is	  not	  known.	  
	  
1.6 Activators	  
	   As	  previously	  mentioned,	  once	  the	  20S	  CP	  has	  been	  assembled	  the	  N-­‐termini	  of	  
the	  a	  subunits	  act	  as	  a	  gate	  closing	  off	  the	  catalytic	  chamber.	  	  In	  order	  to	  allow	  
substrates	  to	  enter	  the	  20S	  CP,	  the	  gate	  must	  be	  opened,	  and	  in	  vivo	  this	  gate	  is	  opened	  
by	  activator	  proteins.	  	  The	  conserved	  function	  of	  proteasomal	  activators	  is	  to	  increase	  
the	  activity	  of	  the	  CP.	  	  Between	  the	  known	  eukaryotic	  activators,	  19S,	  11S	  (aka	  PA28),	  
and	  Blm10,	  each	  has	  been	  shown	  to	  associate	  with	  the	  CP	  and	  increase	  peptidase	  
activity.	  	  	  
	  
1.6.1 AAA	  ATPase	  Activators	  
The	  19S	  regulatory	  particle	  base	  is	  comprised	  of	  six	  Rpt	  proteins	  that	  are	  part	  of	  
the	  AAA	  ATPase	  family	  of	  proteins.	  	  Archaeal	  PAN	  and	  the	  eubacterial	  ARC	  also	  belong	  
to	  this	  family.	  	  Archaeal	  activator	  PAN	  (proteasome-­‐activating	  nucleotidase)	  is	  similar	  to	  
the	  base	  of	  the	  19S	  regulatory	  particle.	  	  It	  is	  a	  ring	  structure	  made	  up	  of	  six	  identical	  AAA	  




(AAA	  ATPase	  forming	  Ring-­‐shaped	  Complexes)	  consists	  of	  six	  identical	  AAA	  ATPase	  
subunits	  that	  form	  a	  ring	  like	  structure	  which	  is	  thought	  to	  activate	  20S	  eubacterial	  
proteasomes	  (Zhang	  et	  al,	  2004).	  	  
In	  the	  base	  of	  the	  19S,	  three	  of	  the	  six	  Rpt	  subunits,	  Rpt2,	  Rpt3,	  and	  Rpt5,	  
contain	  a	  C-­‐terminal	  HbYX	  motif	  (Smith	  et	  al,	  2007).	  	  The	  HbYX	  motif	  is	  a	  tri-­‐peptide	  
sequence	  that	  contains	  a	  hydrophobic	  residue	  (Hb)	  followed	  by	  a	  tyrosine	  (Y)	  plus	  one	  
additional	  residue	  (X).	  When	  binding	  to	  the	  α-­‐ring,	  the	  carboxylate	  of	  the	  X	  residue	  
forms	  a	  salt	  bridge	  with	  a	  lysine	  residue	  (K66	  in	  Thermoplasma	  acidophilum)	  that	  is	  
conserved	  in	  six	  of	  the	  seven	  α	  intersubunit	  pockets	  (Smith	  et	  al,	  2007).	  	  These	  HbYX	  
motifs	  are	  important	  for	  19S	  binding	  and	  are	  responsible	  for	  inducing	  20S	  CP	  gate	  
opening	  (Rabl	  et	  al,	  2008).	  	  Recently,	  the	  pockets	  to	  which	  each	  Rpt	  C-­‐terminal	  tail	  binds	  
to	  were	  mapped	  out	  via	  crosslinking	  assays	  (Tian	  et	  al,	  2011).	  	  Certain	  Rpt	  tails	  occupy	  
fixed	  intersubunit	  pockets,	  such	  as	  Rpt2	  to	  α4,	  Rpt6	  to	  α3,	  and	  Rpt3	  to	  α2.	  Other	  Rpt	  
tails	  have	  a	  degree	  of	  flexibility	  when	  binding	  to	  the	  α-­‐ring	  interface,	  Rpt1	  to	  α6	  and	  α5,	  
Rpt4	  to	  α7	  or	  α1,	  and	  Rpt5	  to	  α6	  or	  α7.	  	  Given	  that	  there	  are	  six	  Rpt	  C-­‐terminal	  tails	  and	  
seven	  intersubunit	  pockets	  on	  the	  α-­‐ring,	  it	  seems	  that	  there	  should	  be	  at	  least	  one	  
unoccupied	  pocket	  on	  the	  CP.	  	  Tian	  et	  al,	  (2011)	  suggested	  that	  there	  are	  different	  
subpopulations	  of	  proteasomes	  where	  the	  flexible	  Rpts	  (1,	  4,	  and	  5)	  may	  occupy	  
different	  pockets	  on	  different	  proteasomes.	  
Since	  the	  initial	  discovery	  of	  the	  archaeal	  20S,	  only	  one	  prokaryotic	  activator	  has	  




nucleotidase).	  	  PAN	  consists	  of	  six	  identical	  ATPases,	  which	  form	  a	  ring	  structure,	  that	  
dock	  on	  to	  one	  or	  both	  α-­‐rings	  of	  the	  20S.	  	  These	  subunits	  all	  contain	  the	  same	  C-­‐
terminal	  HbYX	  motif	  that	  is	  found	  on	  three	  of	  the	  19S	  Rpt	  subunits.	  	  In	  fact,	  the	  HbYX	  
motif	  was	  first	  described,	  and	  shown	  to	  be	  functionally	  relevant,	  in	  PAN	  (Smith	  et	  al,	  
2007).	  	  Additionally,	  the	  eubacterial	  proteasome	  from	  Rhodococcus	  has	  a	  AAA	  ATPase	  
activator	  named	  ARC.	  	  This	  complex	  also	  forms	  a	  six	  membered	  ring	  that	  attaches	  to	  one	  
or	  both	  α-­‐rings	  of	  the	  20S	  CP;	  however,	  unlike	  the	  19S	  and	  PAN	  it	  does	  not	  have	  a	  C-­‐
terminal	  HbYX	  motif	  (Wolf	  et	  al,	  1998).	  	  
1.6.2 11S	  Activator	  
The	  11S	  activator	  (also	  known	  as	  REG	  and	  PA28)	  exists	  in	  two	  forms:	  the	  
heptameric	  complex,	  which	  consists	  of	  PA28α	  and	  PA28β	  subunits,	  or	  a	  homomeric	  
complex	  consisting	  of	  PA28γ	  subunits	  (Rechsteiner	  &	  Hill,	  2005).	  	  The	  two	  different	  11S	  
activators	  appear	  to	  have	  different	  functions.	  	  The	  presence	  of	  11S	  activator	  (PA28αβ)	  is	  
induced	  by	  interferon-­‐γ	  and	  has	  been	  implicated	  in	  having	  a	  role	  in	  the	  formation	  of	  the	  
immunproteasome	  which	  processes	  antigens	  for	  MHC	  class	  I	  ligand	  presentation	  (as	  
reviewed	  by	  (Groettrup	  et	  al,	  2010).	  	  The	  homomeric	  11S	  (PA28γ)	  has	  been	  shown	  to	  
bind	  to	  the	  20S	  CP	  and	  promote	  the	  degradation	  of	  regulatory	  proteins	  (Mao	  et	  al,	  
2008).	  Although	  they	  do	  not	  contain	  C-­‐terminal	  HbYX	  motifs,	  the	  C-­‐termini	  of	  11S	  




1.6.3	   Blm10	  Activator	  
	   Ustrell	  et	  al,	  (2002)	  were	  the	  first	  to	  describe	  Blm10	  (also	  known	  as	  PA200	  in	  
humans)	  as	  a	  proteasomal	  activator	  that	  was	  involved	  in	  DNA	  repair.	  	  Specifically,	  this	  
group	  noted	  that	  Blm10	  was	  capable	  of	  activating	  the	  proteasomal	  hydrolysis	  of	  
peptides,	  but	  not	  proteins	  (Ustrell	  et	  al,	  2002).	  	  
	   Since	  2002,	  others	  have	  suggested	  that	  Blm10	  is	  an	  activator.	  	  Dange	  et	  al,	  (2011)	  
recently	  suggested	  that	  Blm10	  opens	  the	  α-­‐ring	  gate	  in	  the	  same	  manner	  as	  the	  AAA-­‐
ATPase	  activators,	  like	  19S.	  	  Blm10	  is	  a	  monomeric	  structure	  with	  conserved	  C-­‐terminal	  
YYX	  motifs.	  	  The	  work	  done	  by	  Dange	  and	  colleagues	  revealed	  that	  Blm10’s	  penultimate	  
tyrosine	  is	  essential	  for	  core	  particle	  activation.	  This	  suggested	  that	  Blm10’s	  YYX	  motif	  is	  
functionally	  similar	  to	  the	  HbYX	  motif	  found	  in	  AAA-­‐ATPases.	  	  Additionally,	  to	  support	  
the	  notion	  that	  Blm10	  is	  an	  activator,	  Blm10-­‐20S	  proteasomes	  were	  shown	  to	  degrade	  
peptides	  as	  well	  as	  an	  unstructured	  protein,	  tau-­‐441	  (Dange	  et	  al,	  2011).	  	  
	   In	  addition	  to	  being	  an	  activator,	  Blm10	  has	  been	  shown	  to	  be	  important	  in	  the	  
late	  stages	  of	  core	  particle	  maturation.	  	  Like	  many	  chaperone	  proteins	  in	  yeast,	  the	  
deletion	  of	  the	  BLM10	  gene	  does	  not	  have	  any	  obvious	  phenotypical	  defects	  in	  CP	  
maturation	  (Marques	  et	  al,	  2007).	  	  However,	  if	  the	  BLM10	  deletion	  is	  made	  in	  the	  
presence	  of	  a	  mutant	  that	  disrupts	  the	  association	  of	  the	  19S	  RP	  with	  20S	  CP,	  defects	  in	  
20S	  CP	  assembly	  are	  observed	  (Marques	  et	  al,	  2007).	  	  In	  addition,	  Blm10	  has	  been	  
associated	  with	  15S	  intermediates	  (Li	  et	  al,	  2007).	  	  This	  suggests	  that	  Blm10	  has	  




1.7 Chaperone	  Proteins	  
	   Even	  though	  many	  details	  behind	  the	  structure	  and	  function	  of	  the	  26S	  have	  
been	  revealed,	  aspects	  behind	  the	  assembly	  of	  this	  structure	  remain	  unknown.	  Studies	  
in	  yeast	  and	  mammalian	  cells	  have	  illustrated	  20S	  assembly	  as	  a	  regulated	  process	  that	  
involves	  at	  least	  six	  chaperone	  proteins	  in	  Saccharomyces	  cerevisiae:	  Ump1,	  potentially	  
Blm10	  (mentioned	  in	  the	  previous	  section),	  Pba1,	  Pba2,	  Pba3,	  and	  Pba4.	  	  
	  
	  
1.7.1	   Ump1	  
Ump1	  (ubiquitin-­‐mediated	  proteolysis)	  protein	  was	  the	  first	  proteasome	  
chaperone	  to	  be	  identified	  and	  characterized	  (Ramos	  et	  al,	  1998).	  	  Ump1p	  was	  
identified	  through	  a	  screen	  detecting	  mutants	  defective	  in	  degrading	  test	  substrates.	  	  
The	  laboratory	  that	  discovered	  Ump1p	  demonstrated	  through	  pull-­‐down	  experiments	  
that	  Ump1p	  associates	  with	  20S	  proteasomal	  precursors	  that	  contain	  β	  subunits	  with	  
unprocessed	  N-­‐terminal	  propeptides	  (Ramos	  et	  al,	  1998).	  	  Later,	  others	  explicitly	  
demonstrated	  that	  Ump1p	  is	  found	  on	  precursors	  containing	  a	  full	  α-­‐ring	  with	  at	  least	  
three	  β-­‐subunits:	  β2,	  β3,	  and	  β4	  (Li	  et	  al,	  2007).	  	  Ump1p	  ensures	  that	  all	  of	  the	  β	  
subunits	  are	  present	  before	  two	  half-­‐proteasomes	  will	  dimerize.	  	  After	  dimerization,	  
Ump1p	  becomes	  encapsulated	  in	  the	  central	  cavity	  and,	  as	  the	  β	  subunit	  propeptides	  
are	  cleaved,	  Ump1p	  then	  becomes	  the	  first	  substrate	  to	  be	  degraded	  by	  the	  20S	  




When	  UMP1	  is	  deleted	  there	  is	  an	  apparent	  defect	  in	  proteasome	  maturation.	  	  
Not	  only	  are	  there	  fewer	  20S	  and	  26S	  proteasomes	  in	  UMP1	  deleted	  cells,	  but	  also	  there	  
is	  an	  accumulation	  of	  proteasomal	  precursors.	  	  Oddly,	  these	  Ump1p	  lacking	  precursors	  
had	  chymotrypsin-­‐like	  activity.	  	  Normally	  this	  activity	  is	  seen	  in	  β5	  only	  after	  the	  
proteasome	  is	  fully	  assembled	  and	  the	  propeptides	  have	  been	  cleaved.	  	  The	  activity	  of	  
β5	  in	  proteasomeal	  precursors	  lacking	  Ump1p	  suggests	  that	  Ump1p	  may	  normally	  
inhibit	  the	  autocatalytic	  activity	  of	  β5	  (Ramos	  et	  al,	  1998).	  	  More	  recently	  another	  group	  
proposed	  that	  β5	  propeptide	  helps	  drive	  the	  dimerization	  of	  two	  half-­‐proteasomes	  
while	  Ump1p	  acts	  as	  a	  checkpoint	  hindering	  this	  process	  until	  β7	  is	  in	  place	  (Li	  et	  al,	  
2007).	  
1.7.2	   Pba1-­‐Pba2	  
Hirano	  et	  al,	  (2005)	  characterized	  PAC1	  (Proteasome	  Associated	  Chaperone	  1)	  in	  
mammalian	  cells	  along	  with	  a	  second	  protein,	  PAC2.	  	  This	  group	  observed	  PAC1	  and	  
PAC2	  as	  a	  complex	  that	  co-­‐precipitated	  with	  tagged	  proteasome	  subunits.	  	  Additionally,	  
through	  glycerol	  gradient	  centrifugation,	  this	  dimer	  was	  identified	  on	  early	  proteasomal	  
precursors	  containing	  hUmp1	  (human	  Ump1	  protein)	  and	  in	  lighter	  fractions	  that	  lacked	  
hUmp1	  (Hirano	  et	  al,	  2005).	  	  Immunoblots	  of	  the	  fractionated	  proteins	  suggested	  that	  
PAC1	  and	  PAC2	  associate	  with	  α-­‐rings	  and	  may	  promote	  α-­‐ring	  assembly.	  	  Furthermore,	  
immunoblot	  analysis	  of	  the	  lighter	  fractions	  suggested	  that	  PAC1	  and	  PAC2	  associate	  
with	  the	  α5	  and	  α7	  subunits	  early	  in	  assembly	  (Hirano	  et	  al,	  2005).	  	  Next,	  this	  group	  




subunits	  from	  fractions	  corresponding	  to	  α-­‐rings	  to	  fractions	  of	  much	  higher	  (i.e.	  nearly	  
double)	  molecular	  mass.	  	  The	  authors	  reported	  that	  these	  higher	  molecular	  mass	  
complexes	  were	  off-­‐pathway	  intermediates,	  more	  specifically	  α-­‐ring	  dimers	  (Hirano	  et	  
al,	  2005).	  	  	  
The	  gene	  encoding	  PAC2	  was	  reported	  to	  have	  weak	  homology	  with	  ADD66	  
(YKL206C)	  in	  yeast	  (Hirano	  et	  al,	  2005).	  	  Add66	  protein	  was	  characterized	  in	  yeast	  as	  
having	  a	  role	  in	  ERAD	  (Endoplasmic	  Reticulum-­‐associated	  degradation)	  (Scott	  et	  al,	  
2007).	  	  Comparing	  chymotrypsin	  like	  activity,	  ADD66	  mutants	  had	  reduced	  proteasome	  
activity	  relative	  to	  wild-­‐type	  cells.	  	  The	  mutant	  cells	  accumulated	  polyubiquitinated	  
proteins	  and	  20S	  CP	  intermediates	  (Scott	  et	  al,	  2007).	  	  This	  group	  created	  a	  plasmid	  with	  
ADD66	  C-­‐terminally	  tagged	  to	  a	  myc	  epitope.	  	  When	  this	  plasmid	  was	  transformed	  into	  
the	  mutant	  strain,	  polyubiquitinated	  proteins	  no	  longer	  accumulated.	  	  Lastly,	  this	  group	  
suggested	  that	  the	  Add66p	  is	  degraded	  by	  the	  26S	  proteasome	  (Scott	  et	  al,	  2007).	  	  Scott	  
and	  colleagues	  were	  the	  first	  to	  demonstrate	  Add66p	  as	  a	  protein	  that	  facilitates	  
proteasome	  activity	  and	  assembly.	  	  The	  results	  from	  this	  study	  are	  interesting	  because	  
this	  group	  C-­‐terminally	  tagged	  Add66p	  and	  demonstrated	  that	  this	  tagged	  protein	  could	  
relieve	  mutant	  phenotypes	  observed	  in	  ADD66	  mutants.	  	  It	  is	  now	  known	  that	  the	  C-­‐
terminus	  of	  the	  Add66	  (now	  called	  Pba2)	  protein	  is	  important	  for	  20S	  binding	  (see	  
below)	  and	  the	  presence	  of	  a	  C-­‐terminal	  epitope	  tag	  might	  interfere	  with	  this	  binding.	  	  




Similar	  to	  the	  mammalian	  orthologs,	  yeast	  proteasome	  chaperone	  proteins	  Pba1	  
and	  Pba2	  have	  been	  characterized	  as	  a	  heterodimer	  that	  is	  found	  exclusively	  on	  
proteasomal	  precursors	  (Li	  et	  al,	  2007).	  	  Often	  times	  these	  precursors	  contain	  the	  Ump1	  
chaperone	  protein.	  	  Little	  is	  known	  about	  the	  specific	  function	  of	  the	  Pba1p-­‐Pba2p.	  	  In	  
order	  to	  assess	  the	  functional	  importance	  of	  a	  protein,	  deletions	  or	  mutations	  are	  often	  
made.	  	  Interestingly,	  pba1Δ,	  pba2Δ,	  or	  pba1Δpba2Δ	  yeast	  strains	  appear	  to	  grow	  as	  well	  
as	  wild-­‐type	  cells	  (Li	  et	  al,	  2007).	  	  However,	  if	  these	  deletions	  are	  combined	  with	  other	  
mutations	  that	  affect	  proteasome	  function,	  such	  as	  an	  RPN4	  deletion,	  severe	  growth	  
defects	  are	  observed.	  	  Rpn4p	  is	  a	  transcription	  factor	  that	  regulates	  proteasome	  
expression	  levels	  (Xie	  &	  Varshavsky,	  2001).	  	  Even	  though	  no	  growth	  defects	  are	  seen	  in	  
pba1Δ	  and	  pba2Δ	  mutant	  strains,	  they	  do	  demonstrate	  a	  weak	  20S	  assembly	  defect	  (Li	  
et	  al,	  2007).	  	  Li	  et	  al	  (2007)	  demonstrated	  that	  pba2Δ	  cells	  had	  reduced	  levels	  of	  
propeptide	  processing.	  
	   Recently,	  archaeal	  orthologs	  of	  Pba1p	  and	  Pba2p	  were	  identified	  in	  the	  
mesophilic	  methanogen	  Methanococcus	  maripaludis,	  PbaA	  and	  PbaB	  respectively	  
(Kusmierczyk	  et	  al,	  2011).	  	  As	  previously	  mentioned,	  archaeal	  α	  and	  β	  subunits	  will	  self	  
assemble	  into	  20S	  core	  particles	  when	  heterologously	  co-­‐expressed	  in	  E.coli	  (which	  do	  
not	  contain	  20S	  proteasomes),	  therefore	  until	  this	  finding	  it	  was	  assumed	  that	  archaeal	  
proteasome	  biogenesis	  did	  not	  require	  chaperone	  proteins.	  	  An	  in	  vitro	  study	  
demonstrated	  that	  these	  chaperone	  proteins	  associate	  with	  proteasomal	  precursors	  in	  




Where	  Pba1p	  and	  Pba2p	  bind	  on	  the	  20S	  CP	  is	  still	  up	  for	  debate.	  	  As	  previously	  
mentioned,	  Hirano	  et	  al,	  (2005)	  suggested	  that	  the	  mammalian	  orthologs	  to	  these	  
chaperone	  proteins	  associated	  with	  α5	  and	  α7.	  	  However,	  a	  recent	  study	  by	  Park	  et	  al,	  
(2011)	  suggested	  another	  set	  of	  α	  subunits.	  	  Park	  and	  colleagues	  set	  out	  to	  observe	  the	  
interface	  between	  the	  19S	  RP	  and	  the	  α-­‐ring	  of	  the	  20S	  CP.	  	  In	  this	  study	  mutations	  
were	  made	  to	  the	  intersubunit	  pockets	  of	  the	  α-­‐ring,	  so	  that	  the	  normal	  salt	  bridge	  
formed	  between	  the	  Rpts	  of	  the	  19S	  and	  the	  conserved	  lysine	  residue	  of	  the	  α	  subunits	  
would	  be	  disrupted.	  	  When	  this	  group	  performed	  mass	  spectrophotometry	  on	  purified	  
proteasome	  precursor	  complexes	  isolated	  from	  these	  lysine	  mutants,	  they	  revealed	  that	  
the	  α5	  mutant	  had	  significantly	  less	  Pba1p-­‐Pba2p	  present,	  and	  α6	  mutant	  had	  very	  little	  
Pba2p	  present	  and	  no	  detectable	  Pba1p	  (Park	  et	  al,	  2011).	  	  This	  result	  suggested	  that	  
Pba1p	  and	  Pba2p	  may	  be	  interacting	  with	  α5	  and	  α6.	  	  
1.7.3	   Pba3-­‐Pba4	  
	   The	  next	  proteasome	  assembly	  factor	  was	  identified	  in	  mammalian	  cells,	  PAC3.	  	  
It	  was	  characterized	  through	  glycerol	  gradient	  centrifugation	  as	  being	  present	  in	  
fractions	  lighter	  than	  those	  containing	  half-­‐proteasomes	  (Hirano	  et	  al,	  2006).	  	  
Immunoprecipitation	  experiments	  strongly	  suggested	  that	  PAC3	  is	  a	  component	  of	  α-­‐
rings,	  and	  in	  vitro	  binding	  assays	  suggested	  that	  it	  binds	  to	  one	  α	  subunit,	  α2,	  but	  it	  can	  
bind	  to	  several	  of	  the	  β-­‐subunits	  (strongly	  to	  β3	  and	  β4	  and	  weakly	  to	  β1	  and	  β2)	  
(Hirano	  et	  al,	  2006).	  	  Furthermore,	  knockdown	  experiments	  suggested	  that	  PAC3	  is	  




	   Shortly	  after	  the	  first	  characterization	  of	  PAC3,	  Le	  Tallec	  et	  al,	  (2007)	  published	  
data	  characterizing	  four	  chaperone	  proteins	  in	  yeast,	  which	  they	  referred	  to	  as	  Poc1-­‐4p.	  	  
They	  characterized	  PAC1,	  PAC2,	  PAC3,	  and	  the	  uncharacterized	  PAC4	  as	  being	  the	  
mammalian	  homologs	  of	  the	  Poc1-­‐4	  proteins	  found	  in	  yeast	  (Le	  Tallec	  et	  al,	  2007).	  	  
Poc3p	  and	  Poc4p	  were	  shown	  to	  bind/interact	  with	  one	  another.	  	  When	  these	  proteins	  
were	  individually	  expressed	  in	  E.coli,	  they	  were	  insoluble,	  however	  when	  co-­‐expressed	  
these	  proteins	  became	  soluble,	  strongly	  indicating	  an	  interaction	  between	  the	  two	  
proteins.	  	  E.coli	  lysate	  co-­‐expressing	  his-­‐tagged	  Poc3p	  and	  Poc4p	  was	  run	  over	  a	  Ni-­‐
column	  and	  analyzed	  by	  gel	  filtration.	  	  A	  40	  kDa	  complex	  was	  observed,	  the	  Poc3p-­‐
Poc4p	  heterodimer	  (Le	  Tallec	  et	  al,	  2007).	  	  
	  	   Shortly	  after	  the	  Poc3p	  and	  Poc4p	  heterodimer	  was	  identified,	  two	  groups	  
independently	  identified	  this	  chaperone	  and	  published	  data	  on	  the	  functionality	  and	  
localization	  of	  this	  heterodimer,	  which	  they	  called	  Pba3p-­‐Pba4p	  and	  Dmp1p-­‐Dmp2p,	  
respectively	  (Kusmierczyk	  et	  al,	  2008	  and	  Yashiroda	  et	  al,	  2008).	  	  It	  was	  shown	  that	  
these	  proteins	  are	  responsible	  for	  ensuring	  that	  the	  α3	  subunit	  is	  placed	  in-­‐between	  α2	  
and	  α4.	  	  The	  deletion	  of	  PBA3	  and	  PBA4	  genes	  in	  yeast	  does	  not	  cause	  any	  growth	  
defects	  at	  30	  °C,	  however	  they	  have	  mild	  temperature	  sensitivity	  as	  well	  as	  a	  
hypersensitivity	  to	  canavanine.	  	  Like	  other	  Pba	  chaperone	  proteins	  previously	  
mentioned,	  when	  the	  pba3Δpba4Δ	  strain	  was	  combined	  with	  another	  mutation,	  such	  as	  




down	  assays	  suggest	  that	  the	  Pba3p-­‐Pba4p	  complex	  associates	  with	  α5	  and	  possibly	  α1	  
(Kusmierczyk	  et	  al,	  2008).	  
	   Another	  group	  published	  data	  on	  the	  crystal	  structure	  of	  the	  Pba3p-­‐Pba4p	  
heterodimer	  (they	  referred	  to	  these	  proteins	  as	  Dmp1	  and	  Dmp2)	  (Yaroshida	  et	  al,	  
2008).	  	  Even	  though	  this	  group	  stated	  that	  there	  was	  no	  sequence	  similarity	  between	  
Dmp1p	  and	  Dmp2p	  to	  PAC3,	  they	  did	  mention	  that	  the	  structure	  was	  similar	  to	  PAC3.	  	  
Yaroshida	  et	  al,	  (2008)	  demonstrated	  that	  Pba3p-­‐Pba4p	  heterodimer	  could	  interact	  with	  
α5	  and	  α6.	  	  Additionally	  this	  group	  solved	  a	  co-­‐crystal	  structure	  of	  Pba3p-­‐Pba4p-­‐α5	  
(Yashiroda	  et	  al,	  2008).	  	  This	  structure	  explicitly	  demonstrated	  how	  this	  heterodimer	  
interacts	  with	  specific	  non-­‐conserved	  residues	  found	  only	  in	  the	  α5	  subunit.	  	  
1.8 Unanswered	  Questions	  
	   Although	  many	  questions	  remain	  with	  respect	  to	  proteasome	  assembly	  and	  the	  
role	  of	  20S	  assembly	  factors,	  this	  thesis	  will	  focus	  specifically	  on	  the	  Pba1-­‐Pba2	  protein	  
complex.	  	  Despite	  two	  different	  studies	  suggesting	  that	  Pba1p	  and	  Pba2p	  associate	  with	  
specific	  α	  subunits,	  α5	  and	  α7	  (Hirano	  et	  al,	  2005)	  and	  α5	  and	  α6	  (Park	  et	  al,	  2011),	  no	  
study	  to	  date	  has	  shown	  definitively	  where	  Pba1p	  and	  Pba2p	  bind	  on	  the	  20S	  CP	  
intermediates.	  	  Recently,	  a	  group	  revealed	  how	  Pba1p	  and	  Pba2p	  bind	  to	  the	  20S	  CP.	  	  
This	  group	  demonstrated	  that	  Pba1p	  and	  Pba2p	  contain	  functional	  C-­‐terminal	  HbYX	  
motifs.	  	  These	  HbYX	  motifs	  are	  essential	  for	  binding,	  contribute	  to	  assembly	  in	  vivo,	  and	  
are	  partially	  redundant	  with	  one	  another	  (Kusmierczyk	  et	  al,	  2011).	  	  Until	  this	  recent	  




exclusive	  feature	  of	  proteasomal	  activators,	  such	  as	  19S,	  Blm10,	  and	  PAN.	  	  Since	  Pba1p	  
and	  Pba2p	  contain	  HbYX	  motifs,	  they	  should	  bind	  to	  the	  same	  intersubunit	  pockets	  as	  
activator	  HbYX	  motifs	  (Kusmierczyk	  et	  al,	  2011).	  	  
	   Additionally,	  Kusmierczyk	  et	  al,	  (2011)	  characterized	  PbaA,	  an	  archaeal	  ortholog	  
of	  Pba1p.	  	  PbaA	  was	  shown	  to	  bind	  to	  the	  same	  α-­‐ring	  intersubunit	  pockets	  as	  
proteasomal	  activators	  via	  its	  own	  C-­‐terminal	  HbYX	  motif.	  	  This	  data	  all	  the	  more	  
suggests	  that	  Pba1p	  and	  Pba2p	  will	  bind	  to	  the	  intersubunit	  pockets	  of	  the	  α-­‐ring.	  	  I	  
hypothesize	  that	  Pba1p	  and	  Pba2p	  each	  bind	  to	  specific	  α	  intersubunit	  pockets	  on	  20S	  
CP	  intermediates	  via	  C-­‐terminal	  HbYX	  motifs.	  	  This	  work	  aims	  to	  physically	  demonstrate	  





CHAPTER	  2. 	  MATERIALS	  AND	  METHODS	  
2.1 Yeast	  Strains	  and	  Media	  
Yeast	  manipulations	  were	  carried	  out	  according	  to	  standard	  protocols	  (Guthrie,	  
1991).	  	  The	  strains	  used	  in	  this	  study	  are	  listed	  in	  Table	  1.	  	  For	  plating	  and	  cultures	  yeast	  
were	  grown	  in	  rich	  medium	  (YPD)	  or	  minimal	  medium	  (SD-­‐Ura,	  SD-­‐Trp,	  SD-­‐Ura-­‐Trp).	  	  For	  
dilution	  series,	  cultures	  were	  grown	  overnight	  and	  diluted	  to	  an	  OD600	  of	  0.3.	  	  Six-­‐fold	  
dilutions	  were	  prepared	  in	  water	  and	  spotted	  onto	  selective	  media.	  	  Plates	  were	  
incubated	  at	  30	  °C	  or	  37	  °C	  for	  three	  days.	  
The	  plasmids	  used	  in	  this	  study	  are	  listed	  in	  Table	  2.	  	  The	  α	  subunit	  plasmids	  for	  
SCL1,	  PRE8,	  PRE9,	  PRE6,	  PRE5,	  and	  PRE10	  genes	  (α1,	  2,	  3,	  4,	  6,	  and	  7,	  respectively)	  were	  
purchased	  from	  OpenBiosystems.	  	  The	  PRE9	  (α3)	  plasmid	  was	  received	  as	  a	  yeast	  stock,	  
and	  it	  was	  extracted	  from	  yeast	  and	  transformed	  into	  Top10F’	  competent	  E.coli	  cells.	  	  
The	  PUP2	  gene	  (α5)	  was	  cut	  from	  plasmid	  AKB35	  with	  BsrGI	  and	  XbaI	  enzymes	  and	  
pasted	  into	  similarly	  cut	  BG1805	  vector.	  	  In	  α	  subunits	  2-­‐7	  the	  conserved	  lysine	  residue	  
(K66)	  was	  mutagenized	  to	  a	  cysteine	  by	  Quickchange	  mutagenesis	  (Stratagene).	  	  The	  α1	  
subunit	  has	  a	  tyrosine	  residue	  at	  the	  K66	  position,	  and	  it	  was	  also	  mutagenized	  to	  a	  
cysteine	  by	  Quickchange	  mutagenesis.	  	  Each	  of	  the	  plasmid-­‐borne	  α	  subunits	  contains	  a	  




URA3	  gene,	  enabling	  selection	  on	  SD-­‐Ura	  media.	  	  The	  X	  residue	  of	  Pba1p	  and	  Pba2p	  
HbYX	  motifs	  were	  both	  mutagenized	  to	  cysteine	  residues.	  	  In	  brief,	  the	  C-­‐terminal	  end	  of	  
the	  wild-­‐type	  PBA1	  plasmid	  (AKB495)	  was	  PCR	  amplified	  to	  mutagenize	  the	  I276	  residue	  
to	  a	  cysteine.	  	  The	  PCR	  fragment	  was	  ligated	  into	  plasmid	  AKB495	  digested	  with	  XhoI	  
and	  SacI,	  thereby	  replacing	  the	  wild-­‐type	  C-­‐terminus	  with	  a	  mutant	  fragment.	  	  To	  create	  
the	  Pba2p	  HbYX	  mutant,	  Quickchange	  mutagenesis	  was	  performed.	  	  For	  this	  
mutagenesis	  primers	  were	  designed	  with	  a	  point	  mutation	  to	  change	  the	  N267	  residue	  
on	  PBA2	  to	  a	  cysteine.	  	  The	  PBA2	  plasmid	  (AKB490)	  was	  used	  as	  template	  to	  create	  the	  
HbYX	  mutant	  constructs	  containing	  a	  cysteine	  residue	  at	  the	  N267	  position.	  	  DNA	  
sequences	  were	  verified	  by	  DNA	  sequencing.	  	  Both	  PBA1	  and	  PBA2	  are	  expressed	  from	  
their	  endogenous	  promoters.	  	  In	  addition,	  Pba1p	  is	  N-­‐terminally	  tagged	  with	  the	  Flag	  
epitope	  and	  Pba2p	  is	  N-­‐terminally	  tagged	  with	  a	  hexahistidine	  (his)	  tag.	  
2.2 Galactose	  Inductions	  
Yeast	  cultures	  were	  grown	  in	  selective	  media	  overnight	  (SD-­‐Ura-­‐Trp).	  	  The	  OD600	  
was	  measured,	  and	  the	  appropriate	  amount	  of	  culture	  to	  make	  a	  0.2	  OD600	  	  dilution	  in	  
50	  ml	  was	  centrifuged	  in	  a	  1.5	  ml	  Eppendorf	  tube	  at	  5,000	  ×	  g	  for	  5	  minutes.	  	  The	  cells	  
were	  washed	  with	  1	  ml	  of	  ddH2O	  and	  centrifuged	  again	  for	  one	  minute	  at	  5,000	  ×	  g.	  	  
The	  cells	  were	  then	  suspended	  in	  1	  ml	  of	  SDG-­‐Ura-­‐Trp,	  which	  is	  identical	  to	  SD-­‐Ura-­‐Trp	  
except	  galactose	  rather	  than	  glucose	  is	  used	  as	  the	  carbon	  source.	  	  The	  suspension	  was	  
then	  added	  to	  49	  ml	  of	  SDG-­‐Ura-­‐Trp	  in	  a	  250	  ml	  flask.	  	  The	  cultures	  were	  shaken	  at	  30	  °C	  




2.3 Disulfide	  Engineering	  of	  Pba1p	  and	  Pba2p	  to	  α	  Subunits	  
Crosslinking	  of	  Pba1p	  and	  Pba2p	  cysteine	  mutants	  to	  engineered	  cysteine	  
residues	  at	  the	  base	  of	  α	  intersubunit	  pockets	  was	  carried	  out	  essentially	  as	  described	  
(Velichutina	  et	  al,	  2004),	  except	  that	  in	  some	  cases	  the	  cross-­‐linking	  agent	  BMOE	  
(Thermo	  Scientific)	  was	  used	  instead	  of	  CuCl2	  to	  generate	  crosslinks	  (Tian	  et	  al,	  2011).	  	  	  
In	  brief,	  overnight	  yeast	  cultures	  expressing	  engineered	  cysteine	  residues	  were	  
diluted	  to	  an	  OD600	  of	  0.3,	  and	  the	  cultures	  were	  incubated	  on	  a	  rolling	  drum	  at	  30	  °C	  
until	  an	  OD600	  of	  0.8-­‐1.2	  was	  reached.	  	  The	  cultures	  were	  spun	  down	  in	  a	  falcon	  tube	  at	  
4800	  ×	  g	  for	  5	  minutes.	  	  The	  supernant	  was	  poured	  off,	  and	  the	  pellet	  was	  resuspended	  
in	  1	  ml	  of	  ice	  cold	  water	  then	  transferred	  into	  a	  1.5	  ml	  Eppendorf	  tube.	  	  The	  suspension	  
was	  centrifuged	  at	  5,000×	  g	  for	  1	  minute.	  	  The	  supernant	  was	  removed	  then	  the	  pellet	  
was	  resuspended	  in	  100	  µl	  of	  zymolyase	  buffer	  (1.2	  M	  sorbitol,	  50	  mM	  Tris-­‐HCl,	  pH	  8.0,	  
0.5	  mM	  MgCl2)	  supplemented	  with	  30	  mM	  DTT.	  	  After	  incubating	  at	  room	  temperature	  
for	  15	  minutes,	  the	  Eppendorf	  tubes	  were	  centrifuged.	  	  The	  supernant	  was	  removed	  
and	  the	  pellet	  was	  resuspended	  in	  100	  µl	  of	  zymolyase	  buffer	  plus	  4	  µl	  of	  15	  mg/ml	  
zymolyase.	  	  The	  reaction	  was	  incubated	  on	  a	  roller	  at	  30	  °C.	  	  After	  30	  minutes,	  the	  
samples	  were	  centrifuged	  at	  3500	  rpm	  for	  5	  minutes	  at	  room	  temperature.	  	  Next,	  the	  
supernant	  was	  removed	  and	  the	  cells	  were	  washed	  in	  500	  µl	  of	  zymolyase	  buffer.	  	  After	  
another	  5	  minute	  centrifugation,	  the	  supernant	  was	  removed	  and	  100	  µl	  of	  lysis	  buffer	  
(50	  mM	  HEPES,	  pH	  7.5,	  1mM	  EDTA,	  0.1%	  Trition-­‐X100)	  supplemented	  with	  1	  µl	  of	  




reaction	  was	  vortexed	  at	  top	  speed	  for	  30	  seconds	  and	  then	  placed	  on	  ice	  for	  1	  minute;	  
this	  step	  was	  repeated	  3	  times.	  	  The	  Eppendorf	  tubes	  were	  then	  centrifuged	  at	  15,000	  
rpm	  for	  10	  minutes	  at	  room	  temperature.	  	  The	  supernant	  was	  aspirated	  with	  a	  P200	  
Pipetteman	  and	  placed	  into	  a	  fresh	  Eppendorf	  tube.	  	  	  
Alternatively,	  yeast	  cell	  lysis	  was	  performed	  via	  bead	  beating.	  	  Briefly,	  the	  cells	  
were	  harvested	  at	  an	  OD600	  of	  approximately	  1.	  	  The	  cells	  were	  pelleted	  by	  centrifuging	  
at	  5,000	  ×	  g	  or	  5	  minutes.	  	  The	  supernant	  was	  removed,	  and	  the	  cells	  were	  washed	  with	  
1	  ml	  of	  ice-­‐cold	  ddH2O.	  	  The	  cells	  were	  pelleted	  again,	  and	  resuspended	  in	  300	  µl	  of	  
chilled	  lysis	  buffer	  (50	  mM	  Hepes,	  pH	  7.5,	  5	  mM	  MgCl2,	  1	  mM	  DTT).	  	  Approximately	  100	  
µl	  of	  acid	  washed	  glass	  beads	  were	  added	  to	  the	  Eppendorf	  tube,	  and	  the	  tubes	  were	  
vortexed	  on	  high	  for	  3	  ×	  3	  min	  with	  three	  minute	  intervals	  on	  ice	  in-­‐between	  each	  round	  
of	  vortexing.	  	  The	  Eppenorf	  tubes	  were	  then	  centrifuged	  on	  high	  for	  ten	  minutes	  at	  
room	  temperature.	  	  The	  supernant	  was	  removed	  and	  placed	  into	  a	  fresh	  Eppendorf	  
tube	  for	  subsequent	  crosslinking.	  
Crosslinking	  was	  induced	  with	  0.2	  mM	  CuCl2	  at	  room	  temperature	  (Velichutina	  et	  
al,	  2004)	  or	  on	  ice	  with	  0.1	  mM	  BMOE	  purchased	  from	  Thermo	  Scientific	  (Tian	  et	  al,	  
2011).	  	  At	  60	  minutes	  10	  µl	  of	  Stop	  Solution	  (10	  mM	  sodium	  iodoacetate	  and	  50	  mM	  N-­‐
ethyl	  maleimide)	  were	  added	  to	  the	  100	  µl	  lysate	  of	  CuCl2	  reaction	  and	  placed	  on	  ice.	  	  
The	  BMOE	  reactions	  were	  quenched	  with	  10	  mM	  of	  DTT.	  Prior	  to	  adding	  BMOE	  to	  the	  
control	  samples,	  1	  mM	  ATP	  and	  5	  mM	  MgCl2	  were	  added	  to	  the	  lysate	  and	  incubated	  at	  




2.4 Pull-­‐down	  Assays	  
After	  crosslinking,	  some	  samples	  were	  subjected	  to	  immunoprecipitation	  with	  
M2	  Flag	  Resin	  (Sigma	  Aldrich)	  or	  applied	  to	  His	  SpinTrap	  Ni-­‐NTA	  Columns	  (GE	  
Healthcare).	  	  	  
Immunoprecipitations	  with	  M2	  Flag	  resin	  were	  performed	  using	  40	  µl	  of	  gel	  
suspension.	  	  The	  resin	  was	  first	  pelleted	  at	  8,200	  ×	  g	  for	  30	  seconds,	  and	  the	  
supernatant	  was	  removed.	  	  Before	  adding	  the	  lysate	  to	  the	  resin,	  the	  resin	  was	  washed	  
twice	  with	  TBS.	  	  If	  the	  cells	  were	  lysed	  via	  spheroplast	  lysis	  method,	  then	  80	  µl	  of	  the	  
100	  µl	  lysate	  was	  incubated	  with	  the	  resin	  for	  2	  hours	  to	  overnight	  at	  4	  °C	  while	  rotating	  
gently.	  	  Or	  if	  the	  bead	  beading	  lysis	  method	  was	  performed,	  then	  280	  µl	  of	  the	  300	  µl	  
lysate	  was	  added	  to	  the	  resin	  for	  2	  hours	  to	  overnight	  at	  4	  °C.	  	  After	  incubating	  the	  
lysate	  with	  the	  resin,	  the	  Flag-­‐tagged	  protein	  was	  recovered	  by	  first	  pelleting	  the	  resin	  
and	  removing	  the	  supernatant,	  then	  washing	  the	  resin	  three	  times	  with	  600	  µl	  of	  TBS.	  	  
The	  Flag-­‐tagged	  proteins	  were	  recovered	  by	  boiling	  the	  resin	  in	  20	  µl	  of	  2x	  sample	  buffer	  
or	  eluting	  in	  100	  µl	  of	  flag	  peptide	  (450	  ng/µl)	  for	  2	  to	  4	  hours	  at	  4	  °C	  while	  rotating	  
gently.	  
Sample	  application	  to	  100	  µl	  Ni-­‐NTA	  columns	  was	  carried	  out	  as	  follows.	  	  First,	  
the	  columns	  were	  cleared	  of	  storage	  solution	  by	  centrifuging	  the	  column	  at	  100	  ×	  g	  for	  
30	  seconds.	  	  Next,	  the	  column	  was	  washed	  twice	  with	  600	  µl	  binding	  buffer	  (50	  mM	  
Hepes-­‐NaOH;	  pH	  7.5,	  150	  mM	  NaCl,	  5	  mM	  MgCl2,	  40	  mM	  imidazole).	  	  After	  washing	  the	  
resin,	  the	  lysate	  was	  added	  to	  the	  beads,	  and	  centrifuged	  again.	  	  The	  flow	  through	  was	  




Finally,	  the	  sample	  was	  eluted	  in	  400	  µl	  of	  elution	  buffer	  (50	  mM	  Hepes-­‐NaOH;	  pH	  7.5,	  
500	  mM	  NaCl,	  5	  mM	  MgCl2,	  500	  mM	  imidazole).	  
2.5 TCA	  (Trichloroacetic	  Acid)	  Precipitation	  
Eluted	  samples	  were	  concentrated	  by	  TCA	  precipitation.	  	  For	  each	  eluted	  sample,	  
trichloroacetic	  acid	  was	  added	  to	  a	  final	  concentration	  of	  10%,	  and	  the	  sample	  was	  
incubated	  at	  4	  °C	  for	  15	  minutes.	  	  Samples	  were	  centrifuged	  at	  23,000	  rpm	  for	  10	  
minutes	  to	  pellet	  the	  protein.	  	  The	  supernant	  was	  removed,	  and	  the	  pellet	  was	  washed	  
3	  times	  with	  ice-­‐cold	  acetone.	  	  After	  the	  last	  wash,	  the	  supernant	  was	  removed,	  and	  the	  
pellet	  was	  further	  dried	  at	  100	  °C	  for	  10	  minutes.	  
2.6 SDS-­‐PAGE	  and	  Western	  Blot	  Analysis	  
	   For	  the	  analysis	  of	  the	  disulfide	  crosslinked	  Pba1p	  to	  α6	  and	  Pba2p	  to	  α7,	  SDS-­‐
PAGE	  and	  Western	  blot	  analysis	  was	  carried	  out	  as	  described	  (Chen	  and	  Hochstrasser,	  
1995).	  	  Laemmli	  (2x)	  sample	  buffer	  supplemented	  with	  0.02	  %	  sodium	  iodoacetate,	  0.3	  %	  
SDS,	  4	  %	  glycerol,	  3.2	  mM	  Tris-­‐HCl,	  pH	  6.8,	  and	  a	  trace	  of	  Bromophenol	  Blue	  powder	  
was	  added	  to	  each	  sample.	  	  Samples	  were	  applied	  to	  8	  or	  12	  %	  SDS-­‐PAGE	  gels	  and	  
electrophoresed	  at	  80	  V	  until	  the	  dye	  front	  ran	  off	  the	  bottom	  of	  the	  gel.	  	  The	  proteins	  
on	  the	  gels	  were	  transferred	  to	  Immobilon	  membrane	  (Millipore)	  by	  semi-­‐dry	  or	  wet-­‐
transfer	  methods.	  	  The	  semi-­‐dry	  transfer	  was	  carried	  out	  on	  a	  Bio-­‐Rad	  Trans-­‐Blot.	  	  For	  
the	  semi-­‐dry	  method	  a	  tris-­‐gylcine	  transfer	  buffer	  (25	  mM	  tris,	  192	  mM	  glycine,	  and	  20%	  
methanol)	  was	  used.	  The	  trans-­‐blot	  was	  run	  at	  15	  V	  for	  26	  minutes.	  	  For	  wet	  transfers	  




performed	  in	  essentially	  the	  same	  transfer	  buffer	  as	  previously	  described	  except	  
without	  methanol.	  	  The	  transfer	  was	  run	  130	  minutes	  at	  25	  V.	  	  Immediately	  after	  
transfer,	  the	  membrane	  was	  blocked	  in	  a	  5	  %	  non-­‐fat	  milk-­‐TBS	  solution	  overnight	  at	  4	  °C.	  	  
For	  western	  blot	  analysis,	  the	  following	  primary	  antibodies	  were	  used:	  anti-­‐
hemagglutinin	  (MP	  Biomedical,	  Catalog#	  632191),	  peroxidase	  anti-­‐peroxidase	  complex,	  
or	  PAP,	  (Sigma,	  Catalog#	  P1291),	  anti-­‐tetra-­‐his	  (Qiagen,	  Catalog#	  34670),	  and	  an	  anti-­‐
Flag	  (Sigma,	  Catalog#	  F1804).	  	  Proteins	  with	  hemagglutinin	  (HA)	  and	  Flag	  were	  visualized	  
with	  horseradish	  peroxidase-­‐coupled	  secondary	  antibody,	  Goat	  Anti-­‐Mouse	  
(SouthernBiotech,	  Catalog#	  1070-­‐05).	  	  The	  dilutions	  used	  for	  each	  antibody	  are	  listed	  on	  
Table	  3.	  	  The	  membrane	  was	  exposed	  to	  CL-­‐X	  Posure	  Film	  (Thermo	  Scientific,	  Catalog#	  




CHAPTER	  3. RESULTS	  
3.1 Rationale	  
The	  proposed	  work	  aims	  to	  determine	  which	  α	  intersubunit	  pockets	  the	  Pba1p-­‐
Pba2p	  complex	  interacts	  with	  on	  the	  20S	  CP.	  	  As	  mentioned	  earlier,	  HbYX	  motifs	  of	  20S	  
activators	  insert	  into	  α	  intersubunit	  pockets	  resulting	  in	  the	  formation	  of	  a	  salt-­‐bridge	  
between	  the	  C-­‐terminal	  carboxylate	  of	  the	  HbYX	  motif	  and	  a	  conserved	  lysine	  (K66	  in	  T.	  
acidophilum)	  at	  the	  base	  of	  this	  pocket	  (Figure	  3).	  	  Given	  that	  Pba1p-­‐Pba2p	  both	  contain	  
functional	  HbYX	  motifs	  (Kusmeirczyk	  et	  al,	  2011)	  and	  that	  these	  motifs	  have	  been	  shown	  
to	  be	  necessary	  for	  binding	  to	  20S	  (Kusmeirczyk	  et	  al,	  2011),	  I	  reasoned	  that	  a	  
crosslinking	  approach	  might	  be	  a	  reasonable	  means	  of	  detecting	  Pba1p-­‐Pba2p-­‐20S	  
interaction.	  	  In	  this	  approach	  (Figure	  4),	  the	  C-­‐terminal	  residue	  of	  the	  HbYX	  motif	  in	  
either	  Pba1p	  or	  Pba2p	  is	  mutated	  to	  a	  cysteine,	  as	  is	  the	  pocket	  lysine.	  	  When	  the	  two	  
complexes	  interact	  in	  the	  presence	  of	  mild	  oxidizing	  conditions,	  a	  crosslink	  (disulfide	  
bond)	  should	  be	  formed	  between	  the	  engineered	  cysteine	  residues.	  	  	  
3.2 Mutagenesis	  
In	  order	  to	  conduct	  the	  crosslinking	  assay,	  QuickChange	  Mutagenesis	  was	  
performed	  to	  mutate	  the	  conserved	  α	  subunit	  pocket	  lysine	  residue	  (Figure	  5)	  to	  a	  




Instead	  of	  a	  lysine	  at	  the	  conserved	  position	  (K66	  in	  T.	  acidophilum),	  it	  contains	  a	  
tyrosine	  residue.	  	  For	  completeness,	  this	  tyrosine	  was	  mutagenized	  to	  cysteine.	  	  All	  14	  α	  
subunit	  plasmids	  (seven	  wild-­‐type	  and	  seven	  lysine	  mutants),	  are	  controlled	  by	  a	  
galactose-­‐inducible	  promoter	  and	  contain	  a	  C-­‐terminal	  Tandem	  Affinity	  Purification	  (TAP)	  
tag.	  	  
In	  addition	  to	  the	  α	  subunit	  mutations,	  PBA1	  and	  PBA2	  HbYX	  motifs	  were	  
mutagenized.	  	  The	  wild-­‐type	  PBA1	  plasmid	  used	  was	  previously	  constructed	  with	  an	  N-­‐
terminally	  Flag-­‐tagged	  Pba1p	  expressed	  from	  its	  endogenous	  promoter.	  	  Primers	  were	  
designed	  to	  mutate	  the	  HbYX	  motif,	  X	  residue	  (I276)	  on	  Pba1p	  to	  a	  cysteine.	  	  Using	  the	  
wild-­‐type	  plasmid	  as	  template,	  a	  C-­‐terminal	  fragment	  of	  PBA1	  was	  amplified	  containing	  
this	  mutation.	  	  This	  C-­‐terminal	  fragment	  was	  cut	  and	  ligated	  into	  a	  similarly	  digested	  
wild-­‐type	  plasmid,	  creating	  the	  HbXY	  mutant	  plasmid,	  pba1-­‐C.	  	  The	  wild-­‐type	  PBA2	  
plasmid	  contained	  an	  N-­‐terminally	  his-­‐tagged	  Pba2p	  expressed	  from	  its	  endogenous	  
promoter.	  	  The	  HbYX	  motif,	  X	  residue	  (N267),	  on	  PBA2	  was	  mutagenized	  to	  a	  cysteine	  
via	  QuickChange	  Mutagenesis	  creating	  pba2-­‐C	  plasmid.	  	  
Once	  the	  pba1	  and	  pba2	  HbYX	  mutant	  plasmids	  were	  generated,	  I	  wished	  to	  
demonstrate	  that	  the	  mutations	  would	  not	  affect	  Pba1p-­‐Pba2p	  function.	  	  The	  usual	  
means	  to	  do	  this	  would	  be	  to	  demonstrate	  that	  the	  mutants	  are	  capable	  of	  fully	  
complementing	  pba1Δ	  and	  pba2Δ	  yeast	  strains.	  	  However,	  as	  previously	  mentioned,	  
pba1Δ,	  pba2Δ,	  or	  pba1Δpba2Δ	  do	  not	  have	  any	  obvious	  growth	  defects	  (Li	  et	  al,	  2008).	  	  




these	  mutants	  were	  transformed	  into	  pba1Δ	  or	  pba2Δ	  strains	  that	  also	  contained	  a	  
deletion	  of	  the	  RPN4	  gene.	  	  Rpn4p	  is	  a	  transcription	  factor	  that	  regulates	  proteasome	  
expression	  levels	  (Xie	  et	  al,	  2001).	  	  As	  seen	  in	  Figure	  6,	  the	  rpn4Δ	  deleted	  yeast	  cells	  
themselves	  have	  a	  very	  mild	  growth	  defect	  at	  37	  °C.	  	  However,	  when	  the	  rpn4Δ	  was	  
combined	  with	  the	  pba1Δ	  or	  the	  pba2Δ	  the	  yeast	  cells	  were	  no	  longer	  viable	  at	  37	  °C.	  	  
When	  wild-­‐type	  PBA1	  and	  PBA2	  were	  transformed	  into	  their	  respective	  double	  mutants,	  
growth	  of	  the	  double	  mutants	  at	  37	  °C	  was	  restored.	  	  When	  the	  pba1-­‐C	  and	  pba2-­‐C	  
mutants	  were	  transformed	  into	  their	  respective	  double	  mutants,	  each	  HbYX	  mutant	  was	  
also	  able	  to	  restore	  the	  growth	  to	  the	  same	  extent	  as	  the	  wild-­‐type	  proteins	  (Figure	  6).	  	  
This	  suggested	  that	  mutation	  of	  the	  X	  residue	  on	  the	  HbYX	  motifs	  of	  Pba1p	  or	  Pba2p	  did	  
not	  affect	  Pba1p-­‐Pba2p	  function.	  
3.3 Detecting	  Crosslinks	  with	  HbYX	  mutants	  
Eukaryotic	  proteasomes	  contain	  seven	  unique	  α	  subunits;	  therefore,	  there	  are	  
seven	  possible	  pockets	  to	  which	  Pba1p	  and	  Pba2p	  can	  bind.	  	  I	  relied	  on	  previously	  
published	  data	  to	  initially	  focus	  my	  search	  on	  likely	  interacting	  partners.	  	  Specifically,	  
Hirano	  et	  al.	  (2005)	  had	  shown	  that	  the	  mammalian	  orthologs	  of	  Pba1p-­‐Pba2p,	  PAC1-­‐
PAC2,	  interacted	  with	  α5	  and	  α7.	  	  More	  recently,	  Park	  et	  al,	  (2011)	  suggested	  that	  
Pba1p-­‐Pba2p	  might	  be	  interacting	  with	  the	  lysines	  on	  α5	  and	  α6.	  	  Therefore,	  the	  first	  
series	  of	  experiments	  were	  performed	  using	  crosslinkable	  Pba1p	  and	  α6.	  	  Unless	  noted	  
otherwise	  the	  following	  experiments	  were	  performed	  in	  at	  least	  triplicate	  and	  the	  data	  




3.4 Pba1p-­‐α6	  crosslinking	  
	   To	  detect	  interaction	  between	  Pba1p	  and	  α6,	  specifically	  the	  α5-­‐α6	  intersubunit	  
pocket,	  I	  transformed	  pba1Δ	  yeast	  with	  plasmids	  encoding	  pba1-­‐C	  and	  α6-­‐TAP	  and	  
generated	  whole	  cell	  lysates	  from	  5	  ml	  cultures.	  	  Crosslinking	  was	  initiated	  by	  the	  
addition	  of	  CuCl2	  and	  after	  60	  minutes,	  aliquots	  were	  withdrawn	  and	  analyzed	  by	  
immunoblot	  with	  anti-­‐PAP.	  	  Immunoblot	  analysis	  detected	  the	  predicted	  α6	  TAP-­‐tagged	  
species	  at	  approximately	  44	  kDa	  (Figure	  7A,	  lanes	  1-­‐4,	  9).	  	  However,	  incubation	  of	  whole	  
cell	  lysates	  in	  CuCl2	  did	  not	  stimulate	  a	  detectable	  disulfide	  formation	  between	  Pba1p	  
and	  α6	  (Figure	  7A,	  lanes	  1-­‐4)	  
	   Even	  though	  no	  crosslinking	  was	  observed	  in	  the	  lane	  with	  crosslinkable	  Pba1p	  
and	  crosslinkable	  α6,	  this	  was	  not	  due	  to	  the	  failure	  of	  the	  crosslinking	  method	  itself	  
because	  crosslinking	  was	  observed	  in	  the	  relevant	  control	  samples	  (Figure	  7B).	  	  The	  
control	  strains	  for	  this	  experiment	  were	  obtained	  from	  another	  study	  that	  identified	  α4	  
as	  the	  α	  subunit	  that	  replaces	  α3	  when	  α3	  (the	  only	  non-­‐essential	  20S	  proteasome	  
subunit	  in	  yeast)	  is	  deleted	  (Velichutina	  et	  al,	  2004).	  	  In	  that	  study,	  a	  hexa-­‐histidine	  
tagged	  (his-­‐tagged)	  α4	  subunit	  was	  engineered	  with	  two	  cysteine	  residues	  that	  would	  
be	  in	  close	  proximity	  to	  one	  another	  if	  and	  only	  if	  two	  α4	  subunits	  were	  positioned	  next	  
to	  each	  other	  in	  the	  same	  α	  ring.	  	  Under	  mild	  oxidizing	  conditions,	  the	  α4-­‐α4	  crosslinked	  
species	  is	  easily	  detected	  in	  α3Δ	  yeast,	  and	  this	  interaction	  was	  shown	  to	  be	  sensitive	  to	  
reducing	  agents.	  	  By	  contrast,	  wild-­‐type	  yeast	  (i.e.	  α3,	  not	  α3Δ)	  with	  crosslinkable	  α4	  




species	  because	  in	  these	  yeast	  the	  α3	  subunit	  assumes	  its	  normal	  place	  within	  the	  α-­‐
ring	  (Veluchitina	  et	  al,	  2004).	  	  As	  predicted,	  I	  observed	  that	  CuCl2	  incubation	  of	  whole	  
cell	  lysates	  stimulated	  disulfide	  bond	  formation	  between	  crosslinkable	  α4	  subunits	  in	  
α3Δ	  yeast	  (Figure	  7B,	  +	  lane),	  and	  this	  α4-­‐α4	  crosslinked	  species	  was	  reduced	  in	  the	  
presence	  of	  DTT	  (Figure	  7B,	  +	  DTT	  lane).	  	  As	  expected,	  the	  crosslinkable	  α4	  subunits	  did	  
not	  crosslink	  in	  wild-­‐type	  yeast	  cells	  (Figure	  7B,	  -­‐	  lane).	  	  Thus	  I	  conclude	  that	  the	  failure	  
to	  detect	  Pba1p-­‐α6	  crosslinks	  was	  not	  due	  to	  the	  failure	  of	  the	  assay	  per	  se.	  	  Instead,	  
the	  failure	  was	  likely	  due	  to	  suboptimal	  conditions	  for	  this	  particular	  protein	  pair,	  and	  I	  
decided	  to	  modify	  my	  protocol	  in	  a	  number	  of	  ways	  in	  an	  attempt	  to	  optimize	  the	  assay	  
conditions.	  
	  
3.4.1 Increasing	  Culture	  Size	  
	   One	  possibility	  for	  the	  failure	  to	  observe	  Pba1p-­‐α6	  crosslinks	  is	  that	  the	  
crosslinked	  species	  is	  of	  low	  abundance.	  	  I	  decided	  to	  repeat	  the	  analysis	  using	  increased	  
culture	  volumes.	  	  Anti-­‐PAP	  immunoblot	  analysis	  was	  performed	  on	  CuCl2	  treated	  whole	  
cell	  lysates	  from	  10	  ml	  yeast	  cultures	  (2-­‐fold	  increase	  from	  the	  previous	  experiment)	  
prepared	  in	  the	  same	  manner	  as	  before.	  	  Incubation	  of	  cell	  extracts	  in	  CuCl2	  did	  not	  
stimulate	  a	  detectable	  disulfide	  formation	  between	  Pba1p	  and	  α6	  (Figure	  8A,	  lanes	  1-­‐4).	  	  
Anti-­‐PAP	  immunoblot	  analysis	  detected	  the	  predicted	  α6	  TAP-­‐tagged	  species	  at	  
approximately	  44	  kDa	  (Figure	  8A,	  lanes	  1-­‐4,	  9),	  but	  did	  not	  detect	  any	  bands	  at	  the	  




	   Even	  though	  no	  crosslinking	  was	  observed	  in	  the	  anti-­‐PAP	  immunoblot	  analysis,	  
the	  assay	  again	  was	  performed	  correctly	  as	  demonstrated	  by	  the	  positive	  and	  negative	  
crosslinking	  controls.	  	  CuCl2	  incubation	  of	  whole	  cell	  lysates	  stimulated	  disulfide	  bonds	  
between	  crosslinkable	  α4	  subunits	  in	  α3Δ	  yeast	  (Figure	  8B,	  +	  lane),	  and	  this	  α4-­‐α4	  
crosslinked	  species	  was	  reduced	  in	  the	  presence	  of	  DTT	  (Figure	  8B,	  +	  DTT	  lane).	  	  The	  
crosslinkable	  α4	  subunits	  did	  not	  crosslink	  in	  wild-­‐type	  yeast	  cells	  (Figure	  8B,	  -­‐	  lane).	  
	   The	  above	  analysis	  was	  repeated	  with	  whole	  cell	  lysates	  obtained	  from	  50	  ml	  
cultures.	  Incubation	  of	  cell	  lysates	  in	  CuCl2	  did	  not	  stimulate	  a	  detectable	  disulfide	  
formation	  between	  Pba1p	  and	  α6	  (Figure	  9A,	  lanes	  1-­‐4).	  	  Anti-­‐PAP	  immunoblot	  analysis	  
detected	  the	  predicted	  α6	  TAP-­‐tagged	  species	  at	  approximately	  44	  kDa	  (Figure	  9A,	  lanes	  
1-­‐4,	  9),	  but	  did	  not	  detect	  any	  bands	  at	  the	  predicted	  crosslinked	  species	  size,	  75	  kDa.	  
	   Although	  the	  Pba1p-­‐α6	  crosslinked	  species	  was	  not	  observed	  in	  the	  anti-­‐PAP	  
immunoblot	  analysis,	  the	  assay	  was	  performed	  correctly	  as	  demonstrated	  by	  the	  
positive	  and	  negative	  crosslinking	  controls	  as	  described	  above	  (Figure	  9B).	  
3.4.2 Larger	  Cultures	  and	  MG132	  
	   After	  not	  observing	  a	  crosslink	  in	  the	  lysate	  from	  50	  ml	  cultures,	  the	  next	  set	  of	  
experiments	  focused	  on	  increasing	  the	  binding	  affinity	  of	  Pba1p	  to	  the	  20S	  core	  particle	  
intermediates.	  	  Prior	  to	  crosslinking,	  the	  lysate	  was	  incubated	  in	  proteasome	  inhibitor	  
MG132.	  	  Proteasome	  inhibitor	  MG132	  is	  a	  reversible	  inhibitor	  that	  blocks	  the	  
chymotrypsin	  like	  activity	  of	  the	  proteasome.	  	  Other	  groups	  have	  demonstrated	  that	  




proteasome	  (Hirano	  et	  al,	  2005	  and	  Kusmierczyk	  et	  al,	  2011).	  	  I	  reasoned	  that	  it	  might	  
be	  possible	  to	  increase	  crosslinking	  efficiency	  by	  boosting	  the	  affinity	  of	  20S	  for	  Pba1p	  
by	  using	  MG132.	  
	   Prior	  to	  incubating	  the	  lysate	  in	  CuCl2,	  the	  lysates	  were	  incubated	  in	  20	  µM	  
MG132.	  Anti-­‐PAP	  immunoblot	  analysis	  was	  carried	  out	  on	  the	  MG132	  treated	  
crosslinked	  lysate	  as	  described	  above.	  	  Although	  no	  clear	  bands	  were	  observed	  that	  
would	  suggest	  the	  formation	  of	  a	  Pba1p-­‐α6	  crosslink,	  the	  CuCl2	  may	  have	  stimulated	  the	  
formation	  of	  disulfide-­‐linked	  species	  because	  several	  faint	  (non-­‐specific)	  bands	  are	  seen	  
between	  the	  50	  kDa	  and	  the	  75	  kDa	  markers	  (Figure	  10A,	  lanes	  1-­‐4).	  	  Interestingly,	  these	  
bands	  are	  present	  in	  all	  of	  the	  lanes,	  including	  those	  with	  wild-­‐type	  Pba1p	  and	  α6.	  	  
These	  bands	  disappeared	  in	  the	  presence	  of	  DTT	  (Figure	  10A,	  lane	  9)	  consistent	  with	  
them	  being	  the	  result	  of	  some	  kind	  of	  disulfide-­‐linked	  species.	  	  
	  	   The	  crosslinkable	  α4	  control	  samples	  indicated	  that	  the	  crosslinking	  assay	  was	  
performed	  accurately.	  	  CuCl2	  incubation	  of	  whole	  cell	  lysates	  stimulated	  disulfide	  bonds	  
between	  crosslinkable	  α4	  subunits	  in	  α3Δ	  yeast	  (Figure	  10B,	  +	  lane),	  and	  this	  α4-­‐α4	  
crosslinked	  species	  was	  reduced	  in	  the	  presence	  of	  DTT	  (Figure	  10B,	  +	  DTT	  lane).	  	  The	  
crosslinkable	  α4	  subunits	  did	  not	  crosslink	  in	  wild-­‐type	  yeast	  cells	  (Figure	  10B,	  -­‐	  lane).	  
3.4.3 50	  ml	  Cultures,	  MG132,	  and	  Flag	  Pull-­‐Down	  
	   The	  next	  set	  of	  crosslinking	  experiments	  used	  lysate	  obtained	  from	  50	  ml	  
cultures	  and,	  similar	  to	  Figure	  10A,	  these	  samples	  were	  incubated	  with	  proteasome	  




pull-­‐down.	  	  In	  previous	  experiments,	  only	  20	  µl	  of	  the	  100	  µl	  of	  whole	  cell	  lysate	  used	  in	  
the	  crosslinking	  experiment	  could	  be	  loaded	  onto	  the	  gel	  at	  any	  one	  time	  due	  to	  volume	  
constraints	  of	  the	  well.	  	  By	  carrying	  out	  an	  immunoprecipitation	  first,	  I	  should	  be	  able	  to	  
isolate	  all	  of	  the	  Pba1p	  protein	  in	  those	  100	  µl	  of	  lysate	  and	  load	  all	  of	  it	  onto	  the	  gel.	  	  
This	  should	  further	  increase	  the	  odds	  of	  detecting	  a	  crosslinked	  species.	  	  
	   Anti-­‐flag	  immunoprecipiations	  were	  performed	  on	  inhibitor	  treated	  crosslinked	  
lysates	  prepared	  as	  before	  (Figure	  10A).	  	  The	  elutions	  were	  carried	  out	  using	  flag	  
peptide.	  	  Additionally,	  the	  resin	  containing	  both	  crosslinkable	  Pba1p	  and	  α6	  was	  boiled	  
in	  sample	  buffer	  after	  the	  peptide	  elution.	  	  This	  was	  done	  to	  recover	  protein	  that	  may	  
not	  have	  eluted	  off	  the	  beads	  as	  we	  routinely	  observe	  significant	  amounts	  of	  protein	  still	  
attached	  to	  the	  resin	  even	  after	  eluting	  in	  peptide	  (not	  shown).	  	  Unfortunately,	  the	  
elutions	  of	  the	  crosslinked	  lysate	  did	  not	  yield	  the	  expected	  flag-­‐tagged	  Pba1p	  (Figure	  11	  
and	  see	  discussion	  4.1).	  
	  
3.5 Pba2p-­‐α7	  Crosslinking	  
	   In	  parallel	  with	  the	  Pba1p-­‐α6	  crosslinking	  experiments,	  I	  attempted	  to	  visualize	  
crosslinking	  between	  Pba2p	  and	  α7,	  more	  specifically	  the	  α6-­‐α7	  intersubunit	  pocket.	  
These	  experiments	  were	  performed	  in	  duplicate	  and	  representative	  blots	  are	  shown.	  
	   Similar	  to	  the	  Pba1p	  and	  α6	  assays,	  we	  transformed	  pba2Δ	  yeast	  with	  plasmids	  
encoding	  pba2-­‐C	  and	  α7-­‐TAP	  and	  generated	  whole	  cell	  lysates	  from	  5	  ml	  cultures.	  




formation	  between	  Pba2p	  and	  α7	  (Figure	  12A,	  lanes	  1-­‐4).	  	  Anti-­‐PAP	  immunoblot	  
analysis	  detected	  the	  predicted	  α7	  TAP-­‐tagged	  species	  at	  approximately	  50	  kDa	  (Figure	  
12A,	  lanes	  1-­‐4,	  9),	  but	  did	  not	  detect	  any	  bands	  near	  the	  predicted	  crosslinked	  species	  
size,	  80	  kDa.	  
	   Although	  no	  crosslinking	  was	  detected	  via	  anti-­‐PAP	  immunoblot	  analysis,	  the	  
crosslinkable	  α4	  control	  samples	  indicate	  the	  assay	  was	  performed	  correctly.	  	  CuCl2	  
incubation	  of	  whole	  cell	  lysates	  stimulated	  disulfide	  bonds	  between	  crosslinkable	  α4	  
subunits	  in	  α3Δ	  yeast	  (Figure	  12B,	  +	  lane),	  and	  this	  α4-­‐α4	  crosslinked	  species	  was	  
reduced	  in	  the	  presence	  of	  DTT	  (Figure	  12B,	  +	  DTT	  lane).	  	  As	  demonstrated	  in	  other	  
studies	  (Velichutina	  et	  al,	  2004),	  the	  crosslinkable	  α4	  subunits	  did	  not	  crosslink	  in	  wild-­‐
type	  yeast	  cells	  (Figure	  12B,	  -­‐	  lane).	  
	  
3.5.1 Attempts	  to	  Increase	  Crosslinking	  Efficiency	  and	  Detection	  
	   As	  with	  the	  Pba1p-­‐α6	  experiments	  described	  above,	  I	  next	  performed	  anti-­‐PAP	  
immunoblot	  analysis	  on	  whole	  cell	  lysates	  from	  50	  ml	  cultures.	  	  Visualizing	  the	  
crosslinked	  lysate,	  the	  expected	  50	  kDa	  α7	  TAP-­‐tagged	  species	  was	  observed	  (Figure	  
13A,	  lanes	  1-­‐4).	  	  Interestingly,	  the	  sample	  containing	  crosslinkable	  α7	  and	  wild-­‐type	  
Pba2p	  had	  several	  unidentified	  bands	  (Figure	  13A,	  lane	  2).	  	  Additionally	  the	  sample	  
containing	  crosslinkable	  Pba2p	  and	  crosslinkable	  α7,	  also	  had	  several	  unidentified	  bands	  
present	  (lane	  4),	  albeit	  not	  to	  the	  same	  extent	  as	  lane	  2	  (Figure	  13A).	  	  The	  high	  




(Figure	  13A,	  lane	  7)	  suggesting	  that	  they	  are	  the	  result	  of	  a	  disulfide	  linked	  species.	  	  
Unfortunately	  there	  was	  some	  difficulty	  processing	  the	  associated	  control	  samples.	  	  
Namely,	  the	  crosslinked	  α4-­‐α4	  was	  visualized,	  arguing	  that	  the	  crosslinking	  assay	  was	  
working,	  but	  the	  uncrosslinked	  α4	  was	  not	  detected,	  perhaps	  suggestive	  of	  a	  blotting	  
problem	  in	  this	  instance	  (Figure	  13B).	  	  	  
	   The	  next	  series	  of	  immunoblot	  experiments	  were	  performed	  using	  lysate	  
extracted	  from	  50	  ml	  cultures	  and	  incubated	  with	  proteasome	  inhibitor	  MG132	  prior	  to	  
crosslinking.	  	  Moreover,	  the	  lysate	  was	  applied	  to	  a	  Ni-­‐NTA	  column	  in	  order	  to	  increase	  
recovery	  of	  Pba2p,	  based	  on	  the	  same	  reasoning	  for	  carrying	  out	  the	  anti-­‐Flag	  pull	  
downs	  of	  Pba1p.	  	  Anti-­‐PAP	  immunoblot	  analysis	  of	  the	  total	  fractions	  indicated	  that	  the	  
samples	  were	  loaded	  in	  similar	  amounts	  (Figure	  14A).	  	  Although	  I	  did	  not	  observe	  the	  
expected	  crosslinked	  species	  in	  the	  elute	  fractions	  from	  the	  Ni-­‐NTA	  column,	  anti-­‐PAP	  
immunoblot	  analysis	  revealed	  that	  mutant	  α7	  was	  pulled	  down	  by	  both	  the	  wild-­‐type	  
and	  crosslinkable	  his-­‐tagged	  Pba2p	  (Figure	  14B).	  	  The	  α7-­‐TAP	  species	  should	  not	  bind	  
the	  resin	  owing	  to	  the	  fact	  that	  it	  does	  not	  have	  any	  intrinsic	  affinity	  for	  this	  resin.	  	  Both	  
wild-­‐type	  Pba2p	  and	  the	  mutant	  Pba2p	  (N267C)	  pulled	  down	  the	  α7	  mutant	  more	  
efficiently	  than	  the	  wild-­‐type	  α7	  (Figure	  14B).	  	  Even	  though	  a	  crosslinked	  species	  was	  
not	  detected,	  the	  his-­‐tagged	  α4	  crosslinking	  controls	  demonstrated	  that	  the	  assay	  was	  




3.6 Alternative	  Crosslinking	  Approach	  
The	  experiments	  mentioned	  above	  failed	  to	  detect	  the	  Pba1p-­‐α6	  and	  the	  Pba2p-­‐
α7	  crosslinks.	  	  This	  may	  be	  a	  consequence	  of	  mutating	  the	  conserved	  lysine	  residue	  
within	  the	  α	  intersubunit	  pocket.	  	  Mutating	  this	  residue	  to	  a	  cysteine	  may	  have	  
decreased	  the	  affinity	  of	  Pba1p-­‐Pba2p	  to	  the	  20S	  CP.	  	  In	  addition	  to	  possibly	  decreasing	  
the	  affinity,	  my	  initial	  approach	  neglected	  the	  endogenous	  cysteine	  residues	  on	  
neighboring	  subunits.	  	  There	  is	  a	  cysteine	  residue	  on	  α5,	  which	  is	  within	  close	  proximity	  
to	  the	  α5-­‐α6	  pocket,	  and	  there	  is	  another	  cysteine	  on	  α6,	  which	  is	  near	  the	  α6-­‐α7	  
pocket.	  	  These	  endogenous	  cysteines	  may	  have	  interfered	  with	  Pba1p-­‐α6	  and	  Pba2p-­‐α7	  
crosslinking.	  
To	  address	  these	  issues,	  a	  complementary	  crosslinking	  approach	  was	  undertaken	  
based	  on	  yeast	  strains	  developed	  in	  the	  Finley	  laboratory.	  	  This	  laboratory	  developed	  an	  
assay	  to	  determine	  which	  α	  intersubunit	  pockets	  were	  engaged	  by	  which	  HbYX	  motifs	  in	  
Rpt	  subunits	  of	  the	  19S.	  	  Their	  assay	  aimed	  to	  crosslink	  the	  19S	  Rpt	  C-­‐terminal	  tails	  to	  
the	  α	  intersubunit	  pockets	  of	  the	  20S	  CP.	  	  These	  strains,	  similar	  to	  the	  ones	  I	  developed,	  
were	  engineered	  with	  crosslinkable	  α	  subunits;	  however,	  unlike	  my	  approach,	  the	  
crosslinkable	  cysteine	  was	  placed	  on	  the	  side	  of	  the	  α	  intersubunit	  pocket	  (Figure	  15),	  
not	  at	  the	  base	  (Tian	  et	  al,	  2011).	  	  By	  using	  the	  side	  of	  the	  pocket	  to	  crosslink,	  the	  
conserved	  lysine	  residue	  at	  the	  base	  of	  the	  pocket	  remains	  intact.	  	  Additionally,	  this	  
group	  mutated	  the	  endogenous	  cysteine	  residues	  on	  α5	  and	  α6	  to	  alanine	  residues	  in	  




crosslinker	  BMOE.	  	  BMOE,	  bis(maleimido)ethane,	  is	  a	  non-­‐reversible	  crosslinker.	  	  This	  
crosslinker	  has	  an	  advantage	  over	  CuCl2.	  	  The	  BMOE	  molecule	  is	  structured	  so	  that	  it	  
may	  crosslink	  cysteines	  that	  are	  too	  far	  apart	  to	  crosslink	  based	  on	  the	  direct	  formation	  
of	  cys-­‐cys	  disulfides	  under	  mild	  oxidizing	  conditions.	  	  BMOE	  contains	  two	  maleimide	  
groups,	  one	  on	  each	  end	  of	  a	  spacer	  arm.	  	  The	  maleimide	  groups	  form	  stable	  thioether	  
linkages	  to	  sufylhydryl	  groups.	  
Since	  the	  Finley	  lab	  demonstrated	  that	  19S	  Rpt	  tails,	  especially	  those	  containing	  
C-­‐terminal	  HbYX	  motifs	  with	  engineered	  cyteines	  in	  the	  X	  position,	  could	  crosslink	  to	  
these	  mutated	  pockets,	  I	  hypothesized	  that	  my	  engineered	  pba1-­‐C	  and	  pba2-­‐C	  will	  also	  
be	  able	  to	  crosslink	  into	  these	  pockets.	  	  Therefore,	  the	  Finley	  yeast	  strains	  were	  
transformed	  with	  either	  an	  empty	  vector	  or	  vectors	  containing	  wild-­‐type	  PBA1	  or	  pba1-­‐
C.	  	  Additionally,	  these	  crosslinking	  assays	  were	  performed	  with	  crosslinker	  used	  in	  the	  
Rpt	  crosslinking	  assay,	  BMOE.	  
	  
3.6.1 Pba1p-­‐α6	  Crosslinking	  
	   Initially	  I	  attempted	  to	  observe	  crosslinks	  between	  Pba1p	  and	  α6.	  As	  before,	  
whole	  cell	  lysates	  were	  extracted	  from	  50	  ml	  cultures	  and	  incubated	  with	  proteasome	  
inhibitor	  MG132	  prior	  to	  crosslinking.	  	  Crosslinking	  was	  induced	  with	  10	  µM	  BMOE.	  	  The	  
crosslinked	  lysates	  were	  immunoprecipitated	  with	  M2	  anti-­‐Flag	  resin	  to	  isolate	  Pba1p,	  
and	  the	  immunoprecipitates	  were	  analyzed	  by	  immunoblotting	  with	  anti-­‐HA	  antibody	  




pulldown	  lane	  with	  crosslinkable	  Pba1p	  (Figure	  16,	  lane	  6).	  	  Immunoblot	  analysis	  also	  
detected	  a	  faint	  band	  at	  approximately	  60	  kDa	  in	  the	  pba1-­‐C	  pull	  down	  lane,	  consistent	  
with	  the	  position	  of	  a	  crosslinked	  species	  (Figure	  16,	  lane	  6).	  	  This	  band	  was	  not	  
detected	  in	  the	  PBA1	  (WT)	  or	  empty	  vector	  pull	  down	  lanes.	  	  Unexpectedly,	  none	  of	  the	  
relevant	  proteins	  within	  the	  total	  lanes	  (1,	  3,	  and	  5)	  were	  detected	  with	  antibody,	  even	  
though	  protein	  is	  clearly	  present	  in	  the	  pull	  down	  lanes.	  	  This	  anomaly	  may	  be	  attributed	  
to	  inefficient	  lysis	  of	  the	  yeast	  cells.	  	  If	  only	  a	  small	  fraction	  of	  the	  cells	  are	  being	  lysed,	  
then	  the	  total	  fractions	  of	  the	  lysate	  may	  not	  contain	  enough	  protein	  for	  immunoblot	  
detection.	  	  However,	  the	  pull	  down	  lanes	  contain	  concentrated	  amounts	  of	  flag-­‐tagged	  
eluted	  protein;	  therefore,	  proteins	  were	  detectable	  via	  immunoblotting.	  	  
	   To	  overcome	  possible	  lysis	  inefficiency,	  I	  decided	  to	  modify	  the	  analysis	  and	  
switch	  the	  lysis	  method	  from	  spheroplasting	  to	  bead	  beating.	  	  Otherwise,	  the	  
experiment	  was	  carried	  out	  as	  above.	  	  Western	  blot	  analysis	  of	  these	  
immunoprecipitates	  did	  yield	  protein	  in	  the	  total	  lanes	  (Figure	  17,	  lanes	  1,	  3,	  and	  5)	  
consistent	  with	  lysis	  being	  much	  more	  efficient.	  	  Moreover,	  specific	  bands	  were	  present	  
in	  the	  wild-­‐type	  Pba1p	  pull	  down	  lane	  (4)	  and	  the	  crosslinkable	  Pba1p	  pull	  down	  lane	  (6).	  	  
Both	  of	  these	  lanes	  contain	  bands	  at	  approximately	  30	  kDa,	  which	  corresponds	  to	  the	  
approximate	  size	  of	  6×HA-­‐tagged	  α6	  protein.	  	  This	  suggests	  that	  Pba1p	  was	  able	  to	  pull	  
down	  an	  α6-­‐containing	  species	  in	  these	  samples.	  	  Unfortunately,	  the	  lane	  containing	  the	  









CHAPTER	  4. DISCUSSION	  
The	  proteasome	  ubiquitin	  pathway	  has	  been	  shown	  to	  play	  an	  essential	  role	  in	  
many	  highly	  regulated	  cellular	  processes,	  such	  as	  the	  cell	  cycle	  (reviewed	  by	  
Hochstrasser,	  1996).	  	  The	  function	  of	  the	  proteasome	  has	  been	  well	  characterized;	  
however,	  much	  less	  is	  understood	  about	  the	  assembly	  of	  this	  structure.	  	  Studies	  over	  
the	  past	  two	  decades	  have	  indicated	  that	  proteasome	  assembly	  is	  a	  highly	  regulated	  
process.	  	  Within	  eukaryotes	  at	  least	  six	  assembly	  chaperone	  proteins	  have	  been	  
identified:	  Ump1p,	  Pba1p,	  Pba2p,	  Pba3p,	  Pba4p,	  and	  potentially	  Blm10	  (reviewed	  by	  
Kusmierczyk	  &	  Hochstrasser,	  2008).	  
	   My	  work	  focused	  on	  chaperone	  proteins	  Pba1p	  and	  Pba2p.	  	  These	  proteins	  were	  
first	  characterized	  in	  a	  mammalian	  cell	  line	  (Hirano	  et	  al,	  2005)	  and	  later	  in	  yeast	  (Li	  et	  al,	  
2007).	  	  These	  proteins	  were	  shown	  to	  have	  important	  roles	  in	  the	  early	  events	  of	  
assembly	  (Le	  Tallec	  et	  al,	  2007	  and	  Li	  et	  al,	  2007).	  	  Two	  different	  groups	  suggested	  which	  
20S	  subunits	  Pba1p	  and	  Pba2p	  could	  bind	  to;	  however,	  neither	  group	  explicitly	  
demonstrated	  how	  this	  interaction	  was	  mediated	  (Hirano	  et	  al,	  2005	  and	  Park	  et	  al,	  
2011).	  	  Recently,	  Pba1p	  and	  Pba2p	  were	  shown	  to	  bind	  to	  proteasomal	  intermediates	  
via	  their	  C-­‐terminal	  HbYX	  motifs	  (Kusmierczyk	  et	  al,	  2011).	  	  The	  mechanism	  by	  which	  




(Smith	  et	  al,	  2007)	  and	  the	  19S	  RP	  (Rabl	  et	  al,	  2008).	  	  This	  C-­‐terminal	  HbYX	  motif	  has	  
been	  shown	  to	  insert	  itself	  within	  α	  intersubunit	  pockets.	  	  The	  carboxylate	  group	  of	  the	  
X	  residue	  within	  the	  motif	  forms	  a	  salt-­‐bridge	  with	  a	  conserved	  lysine	  residue	  within	  the	  
base	  of	  the	  α	  intersubunit	  pocket	  (Smith	  et	  al,	  2007).	  	  To	  identify	  precisely	  which	  α	  
intersubunit	  pockets	  Pba1p	  and	  Pba2p	  bind,	  I	  attempted	  to	  trap	  this	  interaction	  using	  a	  
crosslinking	  strategy.	  	  The	  X	  residues	  in	  the	  HbYX	  motifs	  of	  Pba1p	  and	  Pba2p	  were	  
mutated	  to	  cysteines,	  which	  itself	  had	  no	  effect	  on	  the	  function	  of	  these	  two	  proteins	  
(Figure	  6).	  	  Similarly,	  each	  of	  the	  conserved	  lysine	  residues	  were	  also	  mutated	  to	  
cysteines,	  and	  I	  attempted	  to	  induce	  cys-­‐cys	  crosslinks	  by	  exposing	  the	  mutated	  proteins	  
to	  mild	  oxidizing	  conditions.	  
	   Other	  studies	  have	  suggested	  that	  Pba1p-­‐Pba2p	  may	  bind	  to	  α5,	  α6,	  or	  α7	  
(Hirano	  et	  al,	  2005	  and	  Park	  et	  al,	  2011).	  	  Therefore,	  my	  experiments	  focused	  on	  
identifying	  a	  crosslink	  between	  Pba1p-­‐Pba2p	  and	  these	  α	  subunits.	  
4.1 Pba1p	  Crosslinking	  
Specifically,	  my	  initial	  experiments	  focused	  on	  detecting	  a	  crosslink	  between	  
Pba1p	  and	  α6.	  	  Even	  though	  several	  attempts	  were	  made	  to	  optimize	  the	  crosslinking	  
conditions	  between	  the	  two	  proteins,	  I	  was	  unable	  to	  detect	  the	  Pba1p-­‐α6	  crosslink.	  	  
Initially,	  I	  looked	  at	  ways	  to	  increase	  the	  likelihood	  of	  detection.	  	  This	  was	  accomplished	  
by	  supplementing	  the	  amount	  of	  Pba1p	  present	  in	  the	  assay.	  	  The	  number	  of	  Pba1p	  
proteins	  present	  in	  the	  cell	  is	  approximately	  1/10	  of	  the	  α	  subunits	  (Ghaemmaghami	  et	  




crosslinked	  signal	  will	  be	  weak.	  	  Therefore,	  if	  all	  of	  the	  Pba1p	  within	  the	  cell	  crosslinked	  
to	  α6,	  the	  crosslinked	  signal	  detected	  via	  anti-­‐PAP	  immunoblotting	  will	  only	  be	  1/10	  the	  
intensity	  of	  the	  α6	  signal.	  	  To	  increase	  the	  signal	  of	  the	  crosslink,	  I	  increased	  the	  protein	  
concentration	  of	  the	  lysate	  2-­‐fold	  and	  then	  10-­‐fold.	  	  Unfortunately,	  the	  above	  
conditions	  failed	  to	  detect	  the	  Pba1p-­‐α6	  crosslink,	  whereas	  the	  assay	  controls	  
consistently	  produced	  a	  crosslink	  (Figures	  9B	  and	  10B).	  	  	  
The	  next	  approach	  taken	  to	  visualize	  the	  crosslink	  involved	  increasing	  the	  
binding	  affinity	  of	  Pba1p	  to	  the	  20S	  CP	  intermediates.	  	  Work	  done	  in	  yeast	  explicitly	  
demonstrated	  that	  exposing	  lysate	  to	  proteasome	  inhibitor	  increased	  the	  binding	  
affinity	  of	  chaperone	  proteins	  to	  the	  20S	  CP	  (Kusmierczyk	  et	  al,	  2011).	  	  The	  next	  series	  of	  
experiments	  incubated	  the	  10-­‐fold	  concentrated	  lysate	  in	  proteasome	  inhibitor	  MG132,	  
prior	  to	  crosslinking.	  	  Again,	  this	  approach	  failed	  to	  detect	  a	  clear	  crosslinked	  species;	  
however,	  several	  faint	  bands	  were	  present	  in	  the	  lanes	  1-­‐4	  (Figure	  10A).	  	  When	  the	  
crosslinked	  sample	  was	  exposed	  to	  DTT,	  the	  faint	  bands	  disappeared	  (lane	  9),	  which	  
strongly	  suggested	  that	  the	  faint	  bands	  seen	  in	  lanes	  1-­‐4	  were	  induced	  by	  CuCl2	  
crosslinking	  (Figure	  10A).	  	  To	  determine	  if	  any	  of	  the	  faint	  bands	  observed	  were	  in	  fact	  
the	  Pba1p-­‐α6	  crosslink,	  the	  next	  method	  used	  the	  proteasome	  inhibitor	  treated	  10-­‐fold	  
larger	  lysate	  in	  combination	  with	  a	  Flag	  pull	  down.	  	  Unfortunately,	  elutions	  of	  this	  





Despite	  attempts	  to	  optimize	  the	  crosslinking	  efficiency	  and	  detection,	  a	  clear	  
crosslink	  was	  never	  observed.	  	  There	  are	  at	  least	  three	  possible	  explanations	  for	  why	  I	  
was	  unable	  to	  detect	  the	  Pba1p-­‐α6	  crosslink.	  	  First,	  it	  is	  possible	  that	  the	  cysteines	  on	  
the	  crosslinkable	  Pba1p	  and	  α6	  were	  never	  close	  enough	  to	  crosslink	  with	  CuCl2.	  	  Under	  
normal	  conditions,	  the	  lysine	  at	  the	  base	  of	  the	  pocket	  forms	  a	  salt-­‐bridge	  with	  the	  
incoming	  C-­‐terminal	  HbYX	  motif	  carboxylate.	  	  The	  lysine	  side	  chain	  has	  four	  methylene	  
groups	  that	  allow	  the	  ε	  amino	  group	  to	  sit	  relatively	  high	  within	  the	  pocket.	  	  In	  contrast,	  
when	  this	  lysine	  was	  mutated	  to	  a	  cysteine,	  the	  length	  of	  the	  side	  chain	  was	  reduced	  by	  
three	  methylene	  groups;	  therefore,	  the	  corresponding	  sulfhydryl	  sits	  lower	  within	  the	  α	  
intersubunit	  pocket.	  	  Perhaps	  this	  extra	  distance	  was	  far	  enough	  to	  prevent	  crosslinking	  
between	  the	  engineered	  cysteine	  residues.	  	  Second,	  mutating	  the	  conserved	  pocket	  
lysine	  residue	  to	  a	  cysteine	  may	  have	  decreased	  the	  binding	  affinity	  of	  Pba1p	  to	  the	  20S	  
CP.	  	  Therefore,	  if	  Pba1p	  is	  no	  longer	  interacting	  with	  α6,	  then	  the	  Pba1p-­‐α6	  crosslink	  
will	  never	  be	  detected.	  	  Indeed,	  recent	  experiments	  by	  Park	  et	  al,	  (2011)	  show	  markedly	  
decreased	  recovery	  of	  Pba1p	  on	  proteasome	  assembly	  intermediates	  containing	  a	  
lysine-­‐to-­‐alanine	  mutation	  of	  the	  α6	  pocket	  lysine,	  and	  my	  project	  was	  initiated	  prior	  to	  
the	  publication	  of	  this	  study.	  	  Third,	  there	  is	  an	  endogenous	  cysteine	  residue	  on	  α5	  that	  
is	  within	  close	  proximity	  to	  the	  α5-­‐α6	  pocket.	  	  This	  endogenous	  cysteine	  may	  have	  
formed	  an	  intra-­‐molecular	  disulfide	  bond	  with	  the	  cysteine	  engineered	  in	  the	  base	  of	  





4.2 Pba2p	  Crosslinking	  
In	  parallel	  to	  the	  Pba1p	  crosslinking,	  my	  work	  focused	  on	  identifying	  the	  
α5, α6, and α7	  intersubunit	  pockets	  as	  potential	  binding	  sites	  for	  Pba2p.	  	  Specifically,	  I	  
focused	  on	  visualizing	  the	  Pba2p-­‐α7	  interaction.	  
Although	  several	  attempts	  were	  made	  to	  optimize	  crosslinking	  efficiency	  and	  
detection,	  I	  failed	  to	  detect	  a	  Pba2p-­‐α7	  crosslink.	  	  Similar	  to	  Pba1p,	  there	  is	  a	  low	  
abundance	  of	  Pba2p	  within	  the	  cell	  (Ghaemmaghami	  et	  al,	  2003).	  	  Therefore,	  the	  
crosslinked	  Pba2p-­‐α7	  band	  will	  not	  be	  easily	  detected.	  	  In	  order	  to	  increase	  the	  
likelihood	  of	  detecting	  the	  Pba2p-­‐α7	  species,	  I	  extracted	  lysate	  from	  larger	  cultures	  to	  
increase	  the	  amount	  of	  Pba2p	  within	  the	  lysate.	  	  When	  the	  lysate	  was	  concentrated	  10-­‐
fold,	  several	  unexpected	  bands	  were	  detected	  via	  anti-­‐PAP	  immunoblot	  analysis.	  	  The	  
samples	  containing	  crosslinkable	  α7	  had	  heavy	  banding	  patterns	  throughout	  the	  lanes.	  	  
Even	  more	  surprisingly,	  the	  sample	  containing	  wild-­‐type	  Pba2p	  and	  crosslinkable	  α7	  had	  
more	  high	  molecular	  weight	  bands	  present	  than	  the	  sample	  containing	  both	  
crosslinkable	  species	  (Figure	  12A).	  	  In	  short,	  the	  reason	  for	  this	  phenomenon	  is	  not	  clear,	  
but	  these	  bands	  only	  occurred	  in	  the	  presence	  of	  a	  crosslinkable	  α7	  subunit.	  	  	  
Since	  none	  of	  the	  high	  molecular	  weight	  bands	  observed	  in	  Figure	  12A	  contained	  
a	  clear	  Pba2p-­‐α7	  crosslink,	  the	  next	  approach,	  similar	  to	  attempts	  made	  in	  the	  Pba1p	  
assays,	  focused	  on	  increasing	  efficiency	  of	  both	  crosslinking	  and	  detection.	  	  To	  increase	  
the	  chances	  of	  crosslinking,	  the	  lysate	  was	  incubated	  in	  proteasome	  inhibitor	  MG132.	  	  




binding	  affinity	  of	  chaperone	  proteins	  to	  the	  20S	  CP	  (Kusmierczyk	  et	  al,	  2011).	  	  
Increasing	  the	  affinity	  of	  Pba2p	  to	  the	  20S	  CP	  should	  increase	  the	  likelihood	  of	  trapping	  
the	  Pba2p-­‐α7	  interaction	  via	  crosslinking.	  	  In	  order	  to	  more	  easily	  detect	  the	  Pba2p-­‐α7	  
crosslink,	  the	  inhibitor	  treated	  crosslinked	  lysate	  was	  run	  over	  a	  Ni-­‐NTA	  column,	  since	  
Pba2p	  is	  N-­‐terminally	  his-­‐tagged.	  	  The	  total	  fractions	  of	  this	  crosslinking	  experiment	  
(Figure	  13A)	  yielded	  similar	  banding	  patterns	  observed	  in	  Figure	  12A.	  	  When	  the	  elute	  
fractions	  were	  analyzed	  by	  anti-­‐PAP	  immunoblot,	  no	  crosslink	  was	  detected;	  however,	  
α7	  was	  present	  in	  the	  elute	  fractions	  (Figure	  13B),	  and	  it	  appeared	  that	  his-­‐tagged	  
Pba2p,	  wild-­‐type	  and	  crosslinkable,	  pulled	  down	  more	  crosslinkable	  α7	  than	  wild-­‐type	  
α7.	  	  This	  suggests	  that	  Pba2p,	  both	  wild-­‐type	  and	  crosslinkable,	  bound	  more	  tightly	  to	  
the	  mutated	  α7	  than	  wild-­‐type	  α7.	  	  	  
Even	  though	  some	  of	  the	  Pba2p-­‐α7	  crosslinking	  assays	  had	  interesting	  results,	  
the	  Pba2p-­‐α7	  crosslink	  was	  never	  detected.	  	  Similar	  to	  the	  Pba1p-­‐α6	  assays	  (mentioned	  
above),	  there	  are	  at	  least	  three	  possible	  explanations	  for	  why	  I	  was	  unable	  to	  detect	  the	  
Pba2p-­‐α7	  crosslink.	  	  First,	  it	  is	  possible	  that	  the	  engineered	  cysteines	  on	  Pba2p	  and	  α7	  
were	  never	  close	  enough	  to	  crosslink.	  	  Second,	  mutating	  this	  conserved	  lysine	  residue	  to	  
a	  cysteine	  may	  have	  decreased	  the	  binding	  affinity	  of	  Pba2p	  to	  the	  20S	  CP.	  	  As	  a	  result,	  if	  
Pba2p	  is	  no	  longer	  interacting	  with	  α7,	  then	  the	  Pba2p	  and	  α7	  will	  never	  crosslink.	  	  
Third,	  there	  is	  an	  endogenous	  cysteine	  residue	  located	  on	  α6	  that	  is	  within	  close	  





4.3 A	  New	  Approach	  
While	  this	  project	  was	  in	  progress,	  another	  group	  published	  crosslinking	  data	  
involving	  the	  interaction	  of	  the	  19S	  Rpt	  C-­‐terminal	  tails	  with	  the	  α	  intersubunit	  pockets	  
of	  the	  20S	  CP	  (Tian	  et	  al,	  2011).	  	  As	  in	  my	  approach,	  this	  group	  took	  advantage	  of	  the	  
known	  HbYX	  interaction.	  	  In	  this	  study	  the	  last	  residue	  of	  the	  C-­‐terminal	  tails	  of	  the	  Rpt	  
subunits	  were	  mutated	  to	  cysteines.	  	  In	  contrast	  to	  my	  approach,	  which	  mutated	  the	  
conserved	  lysine	  residue	  at	  the	  base	  of	  the	  pocket	  to	  a	  cysteine,	  this	  group	  mutated	  a	  
non-­‐conserved	  residue	  on	  the	  side	  of	  the	  pocket,	  keeping	  the	  conserved	  lysine	  residue	  
intact.	  	  Additionally,	  this	  group	  used	  crosslinker	  BMOE	  to	  induce	  the	  formation	  of	  a	  
crosslink	  between	  the	  engineered	  cysteine	  residues.	  	  
By	  using	  these	  yeast	  strains	  to	  crosslink	  Pba1p	  and	  Pba2p	  to	  the	  20S	  CP	  
intermediates,	  the	  potential	  issues	  in	  the	  previous	  approach	  should	  be	  alleviated.	  	  In	  
brief,	  these	  strains	  eliminated	  the	  issue	  of	  decreased	  binding	  affinity	  because	  the	  pocket	  
lysine	  remains	  intact,	  and	  the	  issue	  of	  cysteine	  residue	  proximity	  was	  resolved	  by	  using	  a	  
crosslinking	  agent	  with	  a	  long	  spacer	  arm.	  	  Additionally,	  the	  endogenous	  cysteines	  
located	  near	  the	  potential	  Pba1p	  and	  Pba2p	  binding	  pockets	  were	  mutated	  to	  alanines.	  	  
Considering	  these	  improvements,	  these	  strains	  are	  likely	  to	  crosslink	  with	  my	  
engineered	  Pba1p	  and	  Pba2p	  proteins.	  
4.4 Detection	  Issues	  
Before	  discussing	  the	  results	  of	  the	  crosslinking	  conducted	  with	  the	  new	  strains	  




noted.	  	  In	  the	  beginning	  of	  this	  project,	  there	  were	  no	  issues	  with	  detecting	  proteins	  via	  
immunoblot	  analysis.	  	  However,	  detection	  issues	  arose	  when	  I	  ran	  out	  of	  the	  secondary	  
antibody,	  HRP-­‐conjugated	  Goat	  Anti-­‐Mouse	  (IgGγ1)	  and	  replaced	  it	  with	  a	  new	  aliquot	  
from	  the	  same	  company.	  	  At	  that	  time,	  I	  suddenly	  had	  difficulty	  detecting	  flag-­‐tagged	  
proteins	  (Figure	  11),	  and	  I	  was	  no	  longer	  able	  to	  clearly	  detect	  his-­‐tagged	  proteins	  either	  
(Figures	  13B).	  	  This	  detection	  issue	  became	  even	  more	  apparent	  when	  immunoblot	  
analysis	  of	  the	  crosslinked	  Finley	  strains	  began.	  	  These	  new	  strains	  relied	  on	  a	  secondary	  
HRP-­‐conjugated	  antibody	  to	  visualize	  the	  HA-­‐tagged	  α	  subunits.	  	  After	  several	  weeks	  of	  
troubleshooting,	  it	  was	  finally	  discovered	  that	  the	  newly	  purchased	  secondary	  was	  from	  
a	  different	  production	  lot	  than	  the	  original	  batch,	  and	  this	  lot	  turned	  out	  to	  be	  not	  
functional.	  	  New	  secondary	  antibodies	  have	  since	  resolved	  the	  detection	  issue;	  however,	  
it	  took	  over	  a	  month	  to	  resolve,	  which	  negatively	  impacted	  progress	  of	  this	  project.	  
4.5 Pba1p-­‐α6	  Crosslinking	  (Finley	  Strains)	  
Crosslinking	  with	  the	  Finley	  strains	  was	  performed	  using	  concentrated	  lysate	  
incubated	  in	  proteasome	  inhibitor	  MG132.	  	  Crosslinking	  was	  induced	  with	  BMOE,	  and	  
after	  crosslinking	  total	  fractions	  were	  collected,	  and	  the	  remaining	  lysate	  was	  
immunoprecpitated	  with	  M2	  Flag	  resin.	  	  Oddly,	  no	  protein	  was	  detected	  in	  the	  total	  
fractions;	  however,	  proteins	  were	  detected	  in	  the	  pull	  down	  lanes.	  	  Specifically,	  the	  pull	  
down	  lane	  containing	  crosslinkable	  Pba1p	  had	  a	  band	  at	  approximately	  60	  kDa,	  which	  
corresponds	  to	  the	  expected	  size	  of	  a	  Pba1p-­‐α6	  crosslinked	  species.	  	  This	  band	  was	  not	  




that	  this	  band	  may	  in	  fact	  be	  the	  crosslinked	  Pba1p-­‐α6.	  	  In	  addition	  to	  the	  60	  kDa	  band,	  
a	  band	  at	  approximately	  30	  kDa	  was	  observed	  in	  the	  pull	  down	  lane	  with	  crosslinkable	  
Pba1p.	  	  This	  may	  be	  the	  α6-­‐HA	  tagged	  species	  since	  its	  approximate	  size	  is	  30	  kDa,	  and	  
again	  this	  band	  was	  not	  observed	  in	  the	  empty	  vector	  or	  wild-­‐type	  Pba1p	  pull	  down	  
lanes.	  	  The	  proteins	  seen	  in	  the	  pull	  down	  lanes	  are	  the	  result	  of	  anti-­‐flag	  elutions,	  so	  
the	  detected	  proteins	  are	  present	  because	  they	  are	  either	  flag-­‐tagged	  or	  associating	  
with	  the	  flag-­‐tagged	  protein,	  Pba1p-­‐flag.	  	  Even	  though	  bands	  observed	  in	  the	  
crosslinkable	  Pba1p	  pull	  down	  lane	  were	  promising,	  no	  protein	  was	  detected	  in	  the	  total	  
fractions.	  	  I	  suspected	  this	  may	  be	  due	  to	  inefficient	  lysis,	  so	  I	  repeated	  the	  above	  
experiment	  and	  changed	  the	  lysis	  method	  from	  spheroplasting	  to	  bead	  beating.	  	  
Switching	  the	  lysis	  method	  did	  produce	  detectable	  amounts	  of	  protein	  in	  the	  total	  
fractions	  (Figure	  17).	  	  Additionally,	  potential	  α6-­‐HA	  bands	  were	  detected	  at	  
approximately	  30	  kDa	  in	  the	  Pba1p	  wild-­‐type	  and	  crosslinkable	  pull	  down	  lanes;	  
however,	  a	  crosslink	  was	  not	  detected	  via	  anti-­‐HA	  immunoblot.	  	  Failure	  to	  detect	  a	  
crosslink	  may	  be	  a	  consequence	  of	  the	  new	  lysis	  method.	  	  Bead	  beating	  allowed	  for	  
detectable	  amounts	  of	  protein	  within	  the	  total	  lanes,	  but	  bead	  beating	  has	  been	  
implicated	  in	  disrupting	  protein-­‐protein	  interactions,	  potentially	  due	  to	  sample	  foaming	  
and/or	  heating.	  	  So	  it	  is	  possible	  that	  the	  proteasomal	  intermediates	  within	  this	  lysate	  
were	  damaged,	  due	  to	  the	  forces	  placed	  on	  the	  cells	  during	  the	  bead	  beating.	  	  This	  
could	  potentially	  interfere	  with	  Pba1p	  interacting	  with	  the	  20S	  CP.	  	  Another	  possibility	  




endogenous	  Pba1p.	  	  When	  the	  endogenous	  Pba1p	  interacts	  with	  the	  α5-­‐α6	  pocket,	  it	  
will	  compete	  with	  the	  cys	  mutant	  for	  this	  pocket	  and	  thus	  decrease	  the	  likelihood	  of	  the	  
engineered	  Pba1p	  interacting	  and	  subsequently	  crosslinking	  to	  the	  α5-­‐α6	  pocket.	  	  
Fortunately,	  this	  can	  be	  overcome	  (see	  4.7).	  
4.6 Conclusions	  
Despite	  several	  attempts,	  I	  was	  unable	  to	  detect	  the	  Pba1p-­‐α6	  or	  the	  Pba2p-­‐α7	  
crosslinks.	  	  The	  lack	  of	  success	  with	  the	  first	  approach	  may	  be	  due	  to	  one	  or	  a	  
combination	  of	  the	  following	  possibilities:	  the	  cysteines	  being	  too	  far	  apart	  for	  disulfide	  
formation	  under	  mild	  oxidizing	  conditions,	  mutating	  the	  conserved	  lysine	  residue	  may	  
have	  decreased	  the	  affinity	  of	  Pba1p-­‐Pba2p	  to	  the	  20S	  CP,	  and/or	  the	  endogenous	  
cysteines	  found	  on	  α5	  and	  α6	  may	  have	  interfered	  with	  crosslinkable	  Pba1p	  and	  Pba2p	  
crosslinking	  into	  their	  respective	  pockets.	  	  	  
After	  identifying	  these	  potential	  issues,	  an	  alternative	  crosslinking	  approach	  was	  
undertaken	  using	  strains	  from	  another	  crosslinking	  study.	  	  This	  new	  yeast	  background	  
contained	  the	  crosslinkable	  cysteine	  residues	  on	  the	  side	  of	  the	  α	  intersubunit	  pocket,	  
allowing	  the	  conserved	  lysine	  residue	  to	  remain	  intact.	  	  To	  resolve	  any	  discrepancies	  
involving	  the	  distance	  between	  the	  engineered	  cysteine	  residues,	  the	  crosslinking	  was	  
performed	  using	  crosslinker	  BMOE;	  however,	  it	  bears	  mentioning	  that	  the	  Finley	  lab	  also	  
succeeded	  in	  observing	  Rpt-­‐α	  subunit	  crosslinks	  using	  CuCl2	  to	  induce	  cys-­‐cys	  crosslinks,	  
though	  the	  BMOE	  approach	  was	  likely	  more	  efficient	  (Tian	  et	  al,	  2011).	  	  Additionally,	  the	  




to	  alanines	  to	  prevent	  any	  non-­‐specific	  crosslinking.	  	  All	  in	  all,	  this	  new	  strain	  of	  yeast	  
should	  be	  able	  to	  crosslink	  with	  my	  cysteine	  HbYX	  mutant	  Pba1p	  and	  Pba2p	  proteins;	  
however	  due	  to	  time	  constraints,	  I	  was	  only	  able	  to	  perform	  a	  few	  assays	  aiming	  to	  
detect	  the	  Pba1p-­‐α6	  crosslink.	  	  Although	  these	  first	  few	  attempts	  were	  unsuccessful,	  I	  
do	  believe	  that	  crosslinking	  can	  be	  achieved.	  	  
4.7 Future	  Work	  
On	  the	  whole,	  I	  believe	  that	  crosslinking	  is	  a	  feasible	  approach	  to	  identify	  the	  α	  
intersubunit	  pockets	  to	  which	  Pba1p	  and	  Pba2p	  bind.	  	  Even	  though	  I	  plan	  to	  focus	  my	  
attention	  on	  crosslinking	  Pba1p	  and	  Pba2p	  utilizing	  the	  Finley	  strains,	  the	  Pba2p-­‐α7	  
results	  in	  the	  old	  approach,	  I	  believe,	  are	  worth	  further	  investigation	  (Figure	  13B).	  	  Now	  
that	  the	  detection	  issues	  are	  resolved,	  I	  would	  like	  to	  verify	  if	  the	  banding	  patterns	  
observed	  in	  the	  Pba2p	  (WT)	  and	  α7	  cysteine	  sample	  are	  in	  fact	  due	  to	  crosslinking.	  	  This	  
can	  be	  done	  by	  both	  probing	  with	  anti-­‐his	  and	  performing	  reducing	  controls	  on	  all	  of	  the	  
samples.	  	  	  
Since	  the	  Finley	  strain	  α	  intersubunit	  pockets	  have	  been	  shown	  to	  successfully	  
crosslink	  C-­‐terminal	  HbYX	  motifs	  of	  Rpt	  subunits,	  the	  main	  focus	  for	  future	  work	  will	  
involve	  crosslinking	  cysteine	  mutated	  Pba1p	  and	  Pba2p	  to	  the	  α	  intersubunit	  pockets	  in	  
these	  strains.	  	  However,	  before	  the	  next	  crosslinking	  assays	  are	  conducted,	  I	  will	  delete	  
the	  endogenous	  PBA1	  and	  PBA2	  genes	  in	  the	  Finley	  strain	  background.	  	  This	  will	  
eliminate	  the	  possibility	  of	  endogenous	  Pba1p-­‐Pba2p	  interfering	  with	  the	  plasmid-­‐borne	  





































































Table	  2	  	  Plasmids	  Used	  in	  This	  Study.	  


































Table	  3	  	  Antibody	  Dilutions	  Used	  in	  This	  Study.	  
	  
	  


















Figure	  1	  	  Schematic	  of	  Ubiquitination	  
A	  schematic	  of	  a	  protein	  being	  modified	  by	  ubiquitin.	  	  The	  process	  of	  ubiquitination	  is	  an	  
ATP	  dependent	  process	  that	  is	  carried	  out	  by	  three	  different	  enzymes	  E1,	  E2,	  and	  E3.	  	  E1	  
is	  responsible	  for	  activating	  the	  C-­‐terminal	  glycine	  residue	  of	  ubiquitin	  so	  that	  it	  may	  
form	  a	  covalent	  bond	  with	  the	  lysine	  of	  the	  target	  protein.	  	  E2	  and	  E3	  aid	  in	  the	  
attachment	  of	  the	  activated	  ubiquitin	  to	  a	  substrate.	  	  Once	  a	  substrate	  has	  been	  
ubiquitinated,	  that	  attached	  ubiquitin	  may	  under	  go	  several	  rounds	  of	  ubiquitination	  
forming	  a	  ubiquitin	  chain.	  	  The	  additional	  ubiquitin	  proteins	  are	  attached	  via	  E4.	  	  
Attached	  ubiquitin	  proteins	  are	  removed	  from	  the	  substrate	  by	  DUB	  (deubiquitinating	  






Figure	  2	  	  20S	  Assembly	  
The	  current	  picture	  of	  20S	  assembly	  begins	  with	  free	  α and	  β	  subunits	  (bottom	  left).	  	  
The	  dark	  squiggly	  line	  on	  three	  of	  the	  β	  subunits	  corresponds	  to	  the	  propeptides	  found	  
on	  β1,	  β2,	  and	  β5.	  	  The	  first	  step	  in	  assembly	  involves	  the	  formation	  of	  an	  α-­‐ring.	  	  This	  
α-­‐ring	  acts	  a	  scaffold	  for	  β	  subunits	  to	  assemble	  onto.	  	  The	  earliest	  proteasome	  
intermediate	  that	  has	  been	  isolated	  in	  yeast	  is	  the	  15S,	  which	  consists	  of	  one	  full	  α-­‐ring	  
and	  three	  β	  subunits.	  	  Once	  all	  of	  the	  seven	  β	  subunits	  assemble	  to	  an	  α-­‐ring,	  this	  
structure	  is	  referred	  to	  as	  the	  ‘half-­‐proteasome.’	  	  To	  complete	  assembly,	  two	  half-­‐
proteasomes	  will	  dimerize.	  	  Once	  dimerization	  has	  occurred	  the	  propeptides	  are	  
cleaved,	  resulting	  in	  the	  20S	  proteasome.	  	  The	  proteins	  listed	  in	  the	  center	  of	  the	  figure	  
correspond	  to	  known	  chaperone	  proteins	  involved	  in	  20S	  assembly	  (see	  above	  1.7	  








Figure	  3	  	  α-­‐intersubunit	  Binding	  
Activator	  HbYX	  motifs	  have	  been	  shown	  to	  interact	  with	  α	  intersubunit	  pockets.	  	  This	  
figure	  compares	  the	  interaction	  of	  PA26	  (grey)	  and	  PAN	  (green)	  C-­‐termini	  binding	  to	  the	  
α	  intersubunit	  pocket.	  	  PAN	  contains	  a	  C-­‐terminal	  HbYX	  motif	  while	  PA26	  does	  not	  (Yu	  




The side chain of the most critical and most conserved
residue in the HbYX motif, the penultimate tyrosine, forms
specific interactions with a number of residues within the
intersubunit pocket. Its hydroxyl group on the aromatic ring
forms a hydrogen bond with the main chain carbonyl group
of Gly19 near the reverse turn loop of the a-subunit
(Figure 4B). This hydrogen bond appears to be critical for
gate opening because replacement of this tyrosine residue
with a phenylalanine, which also has an aromatic ring but
lacks the hydroxyl group, abolishes PAN’s binding to the 20S
and the stimulation of gate opening (Table I; Smith et al,
2007). In addition to this hydrogen bond, the two positively
charged residues, Arg20 from one a-subunit and Lys33 from
the neighbouring a-subunit, further stabilize the position and
orientation of this penultimate tyrosine by forming a cation–p
interaction (Figure 4B). Although the Arg20 is conserved as a
positively charged residue (arginine or lysine) in both archae-
al and eukaryotic proteasomes, the Lys33 is less conserved in
eukaryotic a-subunits. Finally, the first residue of the HbYX
motif, leucine, forms a hydrophobic interaction with the
hydrophobic patch (Leu21, val24, Leu81, and val82) in the
intersubunit pocket (Figure 4C).
The conformational change in the intersubunit pocket
induced by binding of the HbYX motif
Upon binding of PAN’s C-termini to the intersubunit pocket
formed by two neighbouring a-subunits, the pocket becomes
smaller (Figure 4A). When one a-subunit from the
20S–PA26E102A!PAN9 (the one on the right side in Figure 4A)
is superimposed on one from the 20S, the neighbouring
a-subunit of the 20S–PA26E102A!PAN9 (the one on the left side of
the pocket) is B4 A˚ closer (measured from the movement of
Glu177), thus forming a tighter pocket around the HbYX
motif. Within this tighter pocket, PAN’s C-terminus interacts
with both sides of the pocket. Thus, the binding pocket seems
to undergo an induced-fit conformational change. In contrast,
the pocket changes very subtly, if at all, upon binding of
PA26’s C-terminus (grey in Figure 4A).
When b-rings of the 20S–PA26E102A!PAN9 and 20S are
aligned and superimposed together, the a-subunit of 20S–
PA26E102A!PAN9 appears rotated about 71 from the a-subunit
of 20S. This rotation is hinged around the helix located in the
wedge between the neighbouring b-subunits and connecting
to the loop that forms the narrow substrate entry channel
(Figure 5). Two residues in this channel, Gly127 and Gly128,
have the smallest shift of all the residues in the subunit (0.3
and 0.4 A˚ respectively). This hinge helix (residues 81–104)
has the smallest RMSD of only 0.7 A˚ (Figure 5B). The distal
helix (residues 168–180) has a largest RMSD of 3.2 A˚, and the
Ca atom of Arg178 moved B4.1 A˚. The Ca atom of Pro17 in
the reverse turn loop moved B1.8 A˚. Similarly, when b-rings
of the 20S–PA26E102A!PAN9 and wild-type 20S–PA26 (PDB
1YA7) are superimposed, RMSD of the hinge helix is 0.7 A˚,
of the distal helix is 3.3 A˚, and the Arg178 moved 5.2 A˚.
However, the Pro17 moved only B0.9 A˚ (Supplementary
Figure 2B).
Figure 4 Interactions between PAN’s C-terminus and the 20S intersubunit pocket. (A) Comparison of C-termini’s conformations of PA26 (grey)
and PAN (green) in the intersubunit pocket. The a-subunits on the right of the same pocket was aligned and superimposed. (B) The position of
the tyrosine residue of the C-terminal HbYX motif. (C) Position of the C-terminal HbYX motif in the intersubunit pocket that is represented as
space filling. Positively charged residues are coloured in blue, and negatively charged residues are coloured in red. The white grey are
hydrophobic regions.
Structure of archaeal 20S with PAN’s C-terminus
Y Yu et al








Figure	  4	  	  Crosslinking	  Strategy	  
Schematic	  of	  the	  CuCl2	  induced	  crosslinking	  strategy.	  	  The	  depicted	  interaction	  should	  
occur	  only	  when	  the	  correct	  combination	  of	  crosslinkable	  Pba1p	  (or	  Pba2p)	  and	  

















Figure	  5	  	  α-­‐subunit	  Sequence	  Alignment	  
Yeast	  α	  subunit	  sequence	  alignment.	  	  The	  conserved	  K66	  position	  (using	  numbering	  
from	  the	  archaeon	  T.	  acidophilum)	  is	  indicated	  in	  red.	  	  The	  only	  subunit	  lacking	  the	  










a1   61 DKLLDP-TTVSYIFCISRTIGMVVNGPIPDARNAALRAKAEAAE-FRYKYGYDMPCDVLA 
a2   53 SPLAMSET-LSKVSLLTPDIGAVYSGMGPDYRVLVDKSRKVAHTSYKRIYGEYPPTKLLV 
a3   54 STLLEQDTSTEKLYKLNDKIAVAVAGLTADAEILINTARIHAQN-YLKTYNEDIPVEILV 
a4   52 LKLQDTRITPSKVSKIDSHVVLSFSGLNADSRILIEKARVEAQS-HRLTLEDPVTVEYLT 
a5   56 SPLLES-DSIEKIVEIDRHIGCAMSGLTADARSMIEHARTAAVT-HNLYYDEDINVESLT 
a6   54 DELSS---YQKKIIKCDEHMGLSLAGLAPDARVLSNYLRQQCNY-SSLVFNRKLAVERAG 











Figure	  6	  	  Dilution	  Series	  pba1-­‐C	  pba2-­‐C	  
The	  Pba1p	  and	  Pba2p	  HbYX	  (X	  àC)	  mutations	  do	  not	  affect	  the	  growth	  of	  the	  yeast.	  	  
Yeast	  strains	  were	  transformed	  with	  an	  empty	  vector	  or	  with	  a	  vector	  containing	  the	  
indicated	  PBA	  constructs.	  	  A	  six-­‐fold	  dilution	  series	  of	  liquid	  yeast	  cultures	  were	  spotted	  
on	  to	  SD-­‐Ura	  media	  and	  incubated	  at	  30	  °C	  and	  37	  °C.	  	  The	  HbYX	  mutant	  constructs	  






























Figure	  7	  A	  	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  
Yeast	  strains	  were	  generated	  to	  contain	  either	  wild-­‐type	  (WT)	  Pba1p	  and	  α6	  or	  both	  
Pba1p	  and	  α6	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  come	  within	  
close	  proximity	  of	  one	  another	  if	  the	  α5-­‐α6	  pocket	  is	  the	  correct	  binding	  site	  for	  Pba1p.	  
Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  from	  5	  ml	  cultures	  in	  
0.25	  mM	  CuCl2	  for	  60	  minutes.	  	  Following	  crosslinking,	  samples	  were	  electrophoresed	  
on	  10%	  non-­‐reducing	  SDS-­‐PAGE	  and	  transferred	  to	  PVDF	  membrane.	  	  Crosslinking	  was	  
visualized	  by	  anti-­‐PAP	  immunoblotting.	  	  The	  Pba1-­‐α6	  crosslink	  should	  be	  observed	  in	  
lane	  4	  at	  approximately	  75	  kDa	  (position	  denoted	  with	  *);	  however,	  no	  such	  band	  was	  
detected.	  	  Lanes	  6,	  7,	  and	  8	  are	  the	  crosslinking	  controls.	  	  These	  samples	  were	  visualized	  
with	  Anti-­‐Tetra-­‐His	  antibody	  (Figure	  7B).	  	  Strains	  used	  were	  AKY635	  (lane1),	  AKY636	  
(lane	  2),	  AKY637	  (lane	  3),	  AKY638	  (lanes	  4	  and	  9),	  AKY634	  (lane	  5),	  AKY612,	  and	  AKY613	  
(lanes	  7	  and	  8).	  	  Reducing	  agent	  was	  added	  where	  indicated	  prior	  to	  loading	  the	  gel.	  	  
Lanes	  6-­‐8	  represent	  positive	  control	  samples,	  described	  in	  (B).	  	  E	  denotes	  wild-­‐type	  






























Figure	  7	  B	  	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  Controls	  
Crosslinking	  controls	  for	  Pba1p	  and	  α6	  crosslinking	  (5	  ml).	  	  The	  control	  strains	  contain	  
α4	  subunits	  with	  engineered	  cysteines	  that	  will	  come	  into	  close	  proximity	  if	  two	  α4	  
subunits	  are	  positioned	  next	  to	  each	  other	  within	  an	  α-­‐ring.	  	  Previous	  work	  has	  
demonstrated	  that	  this	  will	  occur	  when	  α3	  is	  deleted	  (Velichutina	  et	  al,	  2004).	  	  For	  this	  
control	  assay	  all	  lanes	  contained	  crosslinkable	  α4	  and	  all	  lanes	  were	  treated	  with	  CuCl2.	  	  
However,	  crosslinking	  occurred	  only	  in	  the	  strains	  where	  α3	  is	  deleted	  (+)	  and	  not	  in	  
strains	  where	  α3	  is	  still	  present	  (-­‐).	  	  The	  crosslinked	  α4-­‐α4	  species	  is	  indicated,	  as	  is	  the	  























Figure	  8	  A	  	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  2-­‐Fold	  Increase	  in	  Protein	  Concentration	  
Yeast	  strains	  were	  generated	  to	  contain	  either	  wild-­‐type	  (WT)	  Pba1p	  and	  α6	  or	  both	  
Pba1p	  and	  α6	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  come	  within	  
close	  proximity	  of	  one	  another	  if	  the	  α5-­‐α6	  pocket	  is	  the	  correct	  binding	  site	  for	  Pba1p.	  	  
Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  from	  10	  ml	  cultures	  in	  
0.25	  mM	  CuCl2	  for	  60	  minutes.	  	  Following	  crosslinking,	  samples	  were	  electrophoresed	  
on	  10%	  non-­‐reducing	  SDS-­‐PAGE	  and	  transferred	  to	  PVDF	  membrane.	  	  Crosslinking	  was	  
visualized	  by	  anti-­‐PAP	  immunoblotting.	  	  The	  Pba1-­‐α6	  crosslink	  was	  expected	  in	  lane	  4	  at	  
approximately	  75	  kDa	  (position	  denoted	  with	  *);	  however,	  no	  such	  band	  was	  detected.	  	  
Lanes	  6,	  7,	  and	  8	  are	  the	  crosslinking	  controls.	  	  These	  samples	  were	  visualized	  with	  Anti-­‐
Tetra-­‐His	  antibody	  (Figure	  8B).	  	  Strains	  used	  were	  AKY635	  (lane1),	  AKY636	  (lane	  2),	  
AKY637	  (lane	  3),	  AKY638	  (lanes	  4	  and	  9),	  AKY634	  (lane	  5),	  AKY612,	  and	  AKY613	  (lanes	  7	  
and	  8).	  	  Reducing	  agent	  was	  added	  where	  indicated	  prior	  to	  loading	  the	  gel.	  	  Lanes	  6-­‐8	  
represent	  positive	  control	  samples,	  described	  in	  (B).	  	  E	  denotes	  wild-­‐type	  yeast	  strain	  


































Figure	  8	  B	  	  Crosslinking	  Controls:	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  2-­‐Fold	  Increase	  in	  Protein	  
Concentration	  
Crosslinking	  controls	  for	  Pba1p	  and	  α6	  crosslinking	  (10	  ml).	  	  The	  control	  strains	  contain	  
α4	  subunits	  with	  engineered	  cysteines	  that	  will	  come	  into	  close	  proximity	  if	  two	  α4	  
subunits	  are	  positioned	  next	  to	  each	  other	  within	  a	  α-­‐ring.	  	  Previous	  work	  has	  
demonstrated	  that	  this	  will	  occur	  when	  α3	  is	  deleted	  (Velichutina	  et	  al,	  2004).	  	  For	  this	  
control	  assay	  all	  lanes	  contained	  crosslinkable	  α4	  and	  all	  lanes	  were	  treated	  with	  CuCl2.	  	  
However,	  crosslinking	  occurred	  only	  in	  the	  strains	  where	  α3	  is	  deleted	  (+)	  and	  not	  in	  
strains	  where	  α3	  is	  still	  present	  (-­‐).	  	  The	  crosslinked	  α4-­‐α4	  species	  is	  indicated,	  as	  is	  the	  



























Figure	  9	  A	  	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  10-­‐Fold	  Increase	  in	  Protein	  Concentration	  
Yeast	  strains	  were	  generated	  to	  contain	  either	  wild-­‐type	  (WT)	  Pba1p	  and	  α6	  or	  both	  
Pba1p	  and	  α6	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  come	  within	  
close	  proximity	  of	  one	  another	  if	  the	  α5-­‐α6	  pocket	  is	  the	  correct	  binding	  site	  for	  Pba1p.	  	  
The	  crosslink	  is	  predicted	  to	  run	  at	  approximately	  75	  kDa	  (position	  denoted	  by	  *).	  
Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  from	  50	  ml	  cultures	  in	  
0.25	  mM	  CuCl2	  for	  60	  minutes.	  	  Following	  crosslinking,	  samples	  were	  electrophoresed	  
on	  10%	  non-­‐reducing	  SDS-­‐PAGE	  and	  transferred	  to	  PVDF	  membrane.	  	  Crosslinking	  was	  
visualized	  by	  anti-­‐PAP	  immunoblotting.	  	  The	  Pba1-­‐α6	  crosslink	  was	  expected	  in	  lane	  4	  at	  
approximately	  75	  kDa	  (position	  denoted	  with	  *);	  however,	  no	  such	  band	  was	  detected.	  	  
Lanes	  6,	  7,	  and	  8	  are	  the	  crosslinking	  controls.	  	  These	  samples	  were	  visualized	  with	  Anti-­‐
Tetra-­‐His	  antibody	  (Figure	  9B).	  	  Strains	  used	  were	  AKY635	  (lane1),	  AKY636	  (lane	  2),	  
AKY637	  (lane	  3),	  AKY638	  (lanes	  4	  and	  9),	  AKY634	  (lane	  5),	  AKY612,	  and	  AKY613	  (lanes	  7	  
and	  8).	  	  Reducing	  agent	  was	  added	  where	  indicated	  prior	  to	  loading	  the	  gel.	  	  Lanes	  6-­‐8	  
represent	  positive	  control	  samples,	  described	  in	  (B).	  	  E	  denotes	  wild-­‐type	  yeast	  strain	  































Figure	  9	  B	  	  Crosslinking	  Controls:	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  10-­‐Fold	  Increase	  in	  
Protein	  Concentration	  
Crosslinking	  controls	  for	  Pba1p	  and	  α6	  crosslinking	  (50	  ml).	  	  The	  control	  strains	  contain	  
α4	  subunits	  with	  engineered	  cysteines	  that	  will	  come	  into	  close	  proximity	  if	  two	  α4	  
subunits	  are	  positioned	  next	  to	  each	  other	  within	  a	  α-­‐ring.	  	  Previous	  work	  has	  
demonstrated	  that	  this	  will	  occur	  when	  α3	  is	  deleted	  (Velichutina	  et	  al,	  2004).	  	  For	  this	  
control	  assay	  all	  lanes	  contained	  crosslinkable	  α4	  and	  all	  lanes	  were	  treated	  with	  CuCl2.	  	  
However,	  crosslinking	  occurred	  only	  in	  the	  strains	  where	  α3	  is	  deleted	  (+)	  and	  not	  in	  
strains	  where	  α3	  is	  still	  present	  (-­‐).	  	  The	  crosslinked	  α4-­‐α4	  species	  is	  indicated,	  as	  is	  the	  























Figure	  10	  A	  	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  10-­‐Fold	  Increase	  in	  Protein	  Concentration	  +	  
MG132	  
Yeast	  strains	  were	  generated	  to	  contain	  either	  wild-­‐type	  (WT)	  Pba1p	  and	  α6	  or	  both	  
Pba1p	  and	  α6	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  come	  within	  
close	  proximity	  of	  one	  another	  if	  the α5-­‐α6	  pocket	  is	  the	  correct	  binding	  site	  for	  Pba1p.	  	  
In	  an	  attempt	  to	  increase	  the	  binding	  affinity,	  the	  lysate	  was	  incubated	  in	  20	  µM	  MG132	  
prior	  to	  crosslinking.	  	  Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  
from	  50	  ml	  cultures	  in	  0.25	  mM	  CuCl2	  for	  60	  minutes.	  	  Following	  crosslinking,	  samples	  
were	  electrophoresed	  on	  10%	  non-­‐reducing	  SDS-­‐PAGE	  and	  transferred	  to	  PVDF	  
membrane.	  	  Crosslinking	  was	  visualized	  by	  anti-­‐PAP	  immunoblotting.	  	  The	  Pba1-­‐α6	  
crosslink	  was	  expected	  in	  lane	  4	  at	  approximately	  75	  kDa	  (position	  denoted	  with	  *);	  
however,	  no	  such	  band	  was	  detected.	  	  Lanes	  6,	  7,	  and	  8	  are	  the	  crosslinking	  controls.	  	  
These	  samples	  were	  visualized	  with	  Anti-­‐Tetra-­‐His	  antibody	  (Figure	  10B).	  	  Strains	  used	  
were	  AKY635	  (lane1),	  AKY636	  (lane	  2),	  AKY637	  (lane	  3),	  AKY638	  (lanes	  4	  and	  9),	  AKY634	  
(lane	  5),	  AKY612,	  and	  AKY613	  (lanes	  7	  and	  8).	  	  Reducing	  agent	  was	  added	  where	  
indicated	  prior	  to	  loading	  the	  gel.	  	  Lanes	  6-­‐8	  represent	  positive	  control	  samples,	  































Figure	  10	  B	  	  Crosslinking	  Controls:	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  10-­‐Fold	  Increase	  in	  
Protein	  Concentration	  +	  MG132	  
Crosslinking	  controls	  for	  Pba1p	  and	  α6	  crosslinking	  (50	  ml	  +	  MG132).	  	  The	  control	  
strains	  contain	  α4	  subunits	  with	  engineered	  cysteines	  that	  will	  come	  into	  close	  
proximity	  if	  two	  α4	  subunits	  are	  positioned	  next	  to	  each	  other	  within	  a	  α-­‐ring.	  	  Previous	  
work	  has	  demonstrated	  that	  this	  will	  occur	  when	  α3	  is	  deleted	  (Velichutina	  et	  al,	  2004).	  	  
For	  this	  control	  assay	  all	  lanes	  contained	  crosslinkable	  α4	  and	  all	  lanes	  were	  treated	  
with	  CuCl2.	  	  However,	  crosslinking	  occurred	  only	  in	  the	  strains	  where	  α3	  is	  deleted	  (+)	  
and	  not	  in	  strains	  where	  α3	  is	  still	  present	  (-­‐).	  	  The	  crosslinked	  α4-­‐α4	  species	  is	  
indicated,	  as	  is	  the	  α4	  monomer.	  	  Reducing	  agent	  DTT	  was	  added	  where	  indicated	  prior	  
























Figure	  11	  	  Pba1p-­‐α6	  CuCl2	  Crosslinking	  10-­‐Fold	  Increase	  in	  Protein	  Concentration	  +	  
MG132	  +	  Flag	  Pull-­‐Down	  
Yeast	  strains	  were	  generated	  to	  contain	  either	  wild-­‐type	  (WT)	  Pba1p	  and	  α6	  or	  Pba1p	  
and	  α6	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  come	  within	  close	  
proximity	  of	  one	  another	  if	  the	  α5-­‐α6	  pocket	  is	  the	  correct	  binding	  site	  for	  Pba1p.	  	  In	  an	  
attempt	  to	  increase	  the	  binding	  affinity,	  the	  lysate	  was	  incubated	  in	  20	  µM	  MG132	  prior	  
to	  crosslinking.	  	  Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  from	  
50	  ml	  cultures	  in	  0.25	  mM	  CuCl2	  for	  60	  minutes.	  	  Following	  crosslinking,	  samples	  were	  
immunoprecipitated	  with	  M2	  Flag	  resin.	  	  The	  elutions	  were	  carried	  out	  as	  indicated,	  and	  
the	  eluates	  were	  electrophoresed	  on	  10%	  non-­‐reducing	  SDS-­‐PAGE	  then	  transferred	  to	  
PVDF	  membrane.	  	  Crosslinking	  was	  visualized	  by	  anti-­‐PAP	  immunoblotting.	  	  The	  Pba1-­‐
α6	  crosslink	  was	  expected	  in	  lanes	  4	  and	  5	  at	  approximately	  75	  kDa	  (position	  denoted	  
with	  *);	  however,	  no	  such	  band	  was	  detected.	  	  Additionally,	  the	  Pba1-­‐Flag	  species	  
should	  have	  been	  observed	  in	  all	  lanes	  (position	  denoted	  with	  **),	  but	  the	  band	  
corresponding	  to	  this	  protein	  was	  not	  detected.	  	  Strains	  used	  were	  AKY635	  (lane1),	  
































Figure	  12	  A	  	  Pba2p-­‐α7	  CuCl2	  Crosslinking	  
Yeast	  strains	  were	  generated	  to	  contain	  either	  wild-­‐type	  (WT)	  Pba2p	  and	  α7	  or	  both	  
Pba2p	  and	  α7	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  come	  within	  
close	  proximity	  of	  one	  another	  if	  the	  α6-­‐α7	  pocket	  is	  the	  correct	  binding	  site	  for	  Pba2p.	  
Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  from	  5	  ml	  cultures	  in	  
0.25	  mM	  CuCl2	  for	  60	  minutes.	  	  Following	  crosslinking,	  samples	  were	  electrophoresed	  
on	  10%	  non-­‐reducing	  SDS-­‐PAGE	  and	  transferred	  to	  PVDF	  membrane.	  	  Crosslinking	  was	  
visualized	  by	  anti-­‐PAP	  immunoblotting.	  	  The	  Pba2-­‐α7	  crosslink	  should	  be	  observed	  in	  
lane	  4	  at	  approximately	  80	  kDa	  (position	  denoted	  with	  *);	  however,	  no	  such	  band	  was	  
detected.	  	  Lanes	  6,	  7,	  and	  8	  are	  the	  crosslinking	  controls.	  	  These	  samples	  were	  visualized	  
with	  Anti-­‐Tetra-­‐His	  antibody	  (Figure	  12B).	  	  Strains	  used	  were	  AKY673	  (lane1),	  AKY674	  
(lane	  2),	  AKY675	  (lane	  3),	  AKY676	  (lanes	  4	  and	  9),	  AKY634	  (lane	  5),	  AKY612	  (lane	  6),	  and	  
AKY613	  (lanes	  7	  and	  8).	  	  Reducing	  agent	  was	  added	  where	  indicated	  prior	  to	  loading	  the	  
gel.	  	  Lanes	  6-­‐8	  represent	  positive	  control	  samples,	  described	  in	  (B).	  	  E	  denotes	  wild-­‐type	  



























Figure	  12	  B	  	  Pba2p-­‐α7	  CuCl2	  Crosslinking	  Controls	  
Crosslinking	  controls	  for	  Pba2p	  and	  α7	  crosslinking	  (5	  ml).	  	  The	  control	  strains	  contain	  
α4	  subunits	  with	  engineered	  cysteines	  that	  will	  come	  into	  close	  proximity	  if	  two	  α4	  
subunits	  are	  positioned	  next	  to	  each	  other	  within	  a	  α-­‐ring.	  	  Previous	  work	  has	  
demonstrated	  that	  this	  will	  occur	  when	  α3	  is	  deleted	  (Velichutina	  et	  al,	  2004).	  	  For	  this	  
control	  assay	  all	  lanes	  contained	  crosslinkable	  α4	  and	  all	  lanes	  were	  treated	  with	  CuCl2.	  	  
However,	  crosslinking	  occurred	  only	  in	  the	  strains	  where	  α3	  is	  deleted	  (+)	  and	  not	  in	  
strains	  where	  α3	  is	  still	  present	  (-­‐).	  	  The	  crosslinked	  α4-­‐α4	  species	  is	  indicated,	  as	  is	  the	  





























Figure	  13	  A	  	  Pba2p-­‐α7	  CuCl2	  Crosslinking	  10-­‐Fold	  Increase	  in	  Protein	  Concentration	  
Yeast	  strains	  were	  generated	  to	  contain	  either	  wild-­‐type	  (WT)	  Pba2p	  and	  α7	  or	  Pba2p	  
and	  α7	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  come	  within	  close	  
proximity	  of	  one	  another	  if	  the	  α6-­‐α7	  pocket	  is	  the	  correct	  binding	  site	  for	  Pba2p.	  
Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  from	  50	  ml	  cultures	  in	  
0.25	  mM	  CuCl2	  for	  60	  minutes.	  	  Following	  crosslinking,	  samples	  were	  electrophoresed	  
on	  10	  %	  non-­‐reducing	  SDS-­‐PAGE	  and	  transferred	  to	  PVDF	  membrane.	  	  Crosslinking	  was	  
visualized	  by	  anti-­‐PAP	  immunoblotting.	  	  The	  Pba2-­‐α7	  crosslink	  should	  be	  observed	  in	  
lane	  4	  at	  approximately	  80	  kDa	  (position	  denoted	  with	  *);	  however,	  no	  such	  band	  was	  
detected.	  	  Lanes	  6,	  8,	  and	  9	  are	  the	  crosslinking	  controls.	  	  These	  samples	  were	  visualized	  
with	  Anti-­‐Tetra-­‐His	  antibody	  (Figure	  13B).	  	  Strains	  used	  were	  AKY673	  (lane1),	  AKY674	  
(lane	  2),	  AKY675	  (lane	  3),	  AKY676	  (lanes	  4	  and	  7),	  AKY634	  (lane	  5),	  AKY612	  (lane	  6),	  and	  
AKY613	  (lanes	  7,	  8,	  and	  9).	  	  Reducing	  agent	  was	  added	  where	  indicated	  prior	  to	  loading	  
the	  gel.	  	  Lanes	  6-­‐8	  represent	  positive	  control	  samples,	  described	  in	  (B).	  	  E	  denotes	  wild-­‐


































Figure	  13	  A	  	  Crosslinking	  Controls:	  Pba2p-­‐α7	  CuCl2	  Crosslinking	  10-­‐Fold	  Increase	  in	  
Protein	  Concentration	  
Crosslinking	  control	  for	  Pba2p	  and	  α7	  crosslinking	  (50	  ml).	  	  The	  control	  strains	  contain	  
α4	  subunits	  with	  engineered	  cysteines	  that	  will	  come	  into	  close	  proximity	  if	  two	  α4	  
subunits	  are	  positioned	  next	  to	  each	  other	  within	  a	  α-­‐ring.	  	  Previous	  work	  has	  
demonstrated	  that	  this	  will	  occur	  when	  α3	  is	  deleted	  (Velichutina	  et	  al,	  2004).	  	  For	  this	  
control	  assay	  all	  lanes	  contained	  crosslinkable	  α4,	  and	  all	  lanes	  were	  treated	  with	  CuCl2.	  
To	  better	  visualize	  the	  assay	  contrast	  and	  brightness	  levels	  were	  adjusted.	  	  The	  inability	  
to	  clearly	  detect	  the	  α4	  monomer	  suggests	  that	  the	  problem	  with	  this	  assay	  is	  not	  
necessarily	  crosslinking,	  but	  a	  detection	  issue.	  	  Reducing	  agent	  DTT	  was	  added	  where	  
























Figure	  14	  A	  	  Total	  Fractions	  of	  Pba2p-­‐α7	  CuCl2	  Crosslinking	  with	  a	  10-­‐Fold	  Increase	  in	  
Protein	  Concentration	  +	  MG132	  +	  Ni-­‐NTA	  Pull-­‐Down	  
Yeast	  strains	  were	  generated	  to	  contain	  either	  wild-­‐type	  (WT)	  Pba2p	  and	  α7	  or	  Pba2p	  
and	  α7	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  come	  within	  close	  
proximity	  of	  one	  another	  if	  the	  α6-­‐α7	  pocket	  is	  the	  correct	  binding	  site	  for	  Pba2p.	  	  Prior	  
to	  crosslinking,	  the	  lysate	  was	  incubated	  in	  20	  µM	  MG132.	  	  Disulfide	  crosslinking	  was	  
induced	  by	  incubating	  whole	  cell	  lysate	  from	  50	  ml	  cultures	  in	  0.25	  mM	  CuCl2	  for	  60	  
minutes.	  	  Lysates	  were	  run	  on	  a	  Ni	  NTA	  column.	  Total	  fractions	  (15	  µl	  of	  the	  100	  µl	  
lysate)	  were	  electrophoresed	  on	  10	  %	  non-­‐reducing	  SDS-­‐PAGE	  and	  transferred	  to	  PVDF	  
membrane.	  The	  samples	  were	  visualized	  by	  anti-­‐PAP	  immunoblotting.	  	  The	  Pba2-­‐α7	  
crosslink	  should	  be	  observed	  in	  lane	  4	  at	  approximately	  80	  kDa	  (position	  denoted	  with	  
*);	  however,	  no	  such	  band	  was	  detected.	  	  Strains	  used	  were	  AKY673	  (lane	  1),	  AKY674	  
(lane	  2),	  AKY675	  (lane	  3),	  AKY676	  (lanes	  4),	  and	  AKY600	  (lane	  5).	  	  N	  denotes	  wild-­‐type	  































Figure	  14	  B	  	  Elute	  Fractions	  of	  Pba2p-­‐α7	  CuCl2	  Crosslinking	  with	  a	  10-­‐Fold	  Increase	  in	  
Protein	  Concentration	  +	  MG132	  +	  Ni-­‐NTA	  Pull-­‐Down	  
Pba2p	  and	  α7	  were	  each	  engineered	  with	  cysteine	  residues.	  	  These	  cysteines	  will	  come	  
within	  close	  proximity	  of	  one	  another	  if	  the	  α7-­‐α6	  pocket	  is	  the	  correct	  binding	  site	  for	  
Pba2p.	  	  Prior	  to	  crosslinking	  the	  lysate	  obtained	  from	  the	  50	  ml	  cultures	  was	  incubated	  
in	  proteasome	  inhibitor	  MG132.	  	  Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  
cell	  lysate	  in	  CuCl2	  for	  60	  minutes.	  	  Lysates	  were	  applied	  to	  a	  Ni	  NTA	  column	  and	  eluted	  
with	  imidazole-­‐containing	  buffer	  as	  described	  in	  the	  materials	  and	  methods.	  	  Samples	  of	  
the	  eluates	  were	  applied	  to	  non-­‐reducing	  10	  %	  SDS-­‐PAGE	  and	  blotted	  to	  PVDF	  prior	  to	  
immunoblot	  analysis	  with	  anti-­‐PAP.	  	  The	  Pba2-­‐α7	  crosslink	  should	  be	  observed	  in	  lane	  9	  
at	  approximately	  80	  kDa	  (position	  denoted	  with	  *);	  however,	  no	  such	  band	  was	  
































Figure	  14	  C	  	  Crosslinking	  Controls:	  Pba2p-­‐α7	  CuCl2	  Crosslinking	  with	  a	  10-­‐Fold	  Increase	  
in	  Protein	  Concentration	  +	  MG132	  +	  Ni-­‐NTA	  Pull-­‐Down	  
Crosslinking	  control	  for	  Pba2p	  and	  α7	  crosslinking	  (50	  ml	  +	  MG132).	  	  The	  control	  strains	  
contain	  α4	  subunits	  with	  engineered	  cysteines	  that	  will	  come	  into	  close	  proximity	  if	  two	  
α4	  subunits	  are	  positioned	  next	  to	  each	  other	  within	  a	  α-­‐ring.	  	  Previous	  work	  has	  
demonstrated	  that	  this	  will	  occur	  when	  α3	  is	  deleted	  (Velichutina	  et	  al,	  2004).	  	  For	  this	  
control	  assay	  all	  lanes	  contained	  crosslinkable	  α4	  and	  all	  lanes	  were	  treated	  with	  CuCl2.	  	  
However,	  crosslinking	  occurred	  only	  in	  the	  strains	  where	  α3	  is	  deleted	  (+)	  and	  not	  in	  
strains	  where	  α3	  is	  still	  present	  (-­‐).	  	  The	  crosslinked	  α4-­‐α4	  species	  is	  indicated,	  as	  is	  the	  
























Figure	  15	  	  Representation	  of	  Finley	  Crosslinking	  Strategy	  
Representation	  of	  the	  Finley	  crosslinking	  strategy.	  	  The	  α4-­‐α5	  (blue)	  intersubunit	  pocket	  
is	  depicted	  along	  with	  the	  C-­‐terminus	  of	  a	  PA26	  subunit.	  	  In	  order	  to	  crosslink	  C-­‐termini	  
into	  the	  intersubunit	  pockets	  specific	  residues	  were	  mutagenized	  to	  cysteines.	  	  A	  non-­‐
conserved	  residue	  on	  the	  side	  of	  the	  pocket,	  Thr82	  residue	  on	  α5,	  was	  mutagenized	  to	  a	  
cysteine.	  	  The	  distances	  between	  the	  C-­‐terminus	  of	  PA26	  and	  Thr82,	  as	  well	  as	  Lys66	  are	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that not all A pockets can be simultaneously occupied in this manner. 
Despite the critical roles played by the regulatory particle–core particle 
interface, its organization has remained unknown.
In this study, we used mutagenesis and cysteine-specific cross-linking 
to probe contacts between the Rpt proteins and the core-particle 
A subunits. The results define the relative arrangement of the 
13 subunits that make up the stacked ring assemblies of the regu-
latory particle–core particle interface and reveal that this inter-
face is unexpectedly asymmetric. Three neighboring Rpt proteins 
insert into specific A pockets, whereas, on the opposite side of the 
Rpt ring, each Rpt tail can be found cross-linked to more than one 
A pocket. These results suggest the existence of several interconvert-
ible populations of proteasomes, which differ in the positioning of 
the unoccupied A pocket. Our findings may explain specific charac-
teristics of the structure of the proteasome as observed by electron 
microscopy17,33–35. Nucleotide affects cross-linking efficiency for 
every A-Rpt pair, suggesting that the engagement between A and Rpt 
subunits is dynamically regulated by ATP hydrolytic cycles, with the 
principal stabilizing contacts alternating from subunit to subunit as 
ATP is bound and hydrolyzed asynchronously.
RESULTS
The regulatory particle–core particle interface
We used chemical cross-linking to investigate the interaction between 
the Rpt and A subunits. We first substituted cysteine in place of the 
C-terminal residue of each Rpt protein, which is a critical residue 
for both the assembly and gating functions of the Rpt tails8,9,29  
(see Supplementary Fig. 1a for sequence alignments of Rpt C termini). 
Its principal feature is thought to be the main chain carboxylate, rather 
than the side chain5,6,8,9. Each carboxylate is proposed to form a salt 
bridge to the E-amino group of a specific A subunit lysine residue9, 
a residue that, for six of the seven A subunits, aligns with K66 in the 
A subunit of the PAN complex (the ‘pocket lysine’). Accordingly, dele-
tion of the C-terminal residue has substantial phenotypic effects for 
most Rpts29. Substitution mutations, which are expected to preserve 
the salt bridge to the pocket lysine, were for the most part well toler-
ated, though under conditions of proteolytic stress, such as high tem-
perature, hypomorphic function could be observed (Supplementary 
Fig. 2 and data not shown). Analysis of purified proteasomes from 
these mutants indicated that the regulatory particle–core particle 
interaction is, depending on context, either not detectably perturbed 
or minimally perturbed (Supplementary Fig. 2).
The introduction of cysteines into the A-ring was guided by the struc-
ture of a complex between PA26 and the yeast core particle9. PA26 is 
a homoheptameric activator of the core particle. Although unrelated 
to the regulatory particle, PA26 also binds the core particle through 
C-terminal tail insertion into the A pockets, and has served as a model 
for regulatory particle–core particle interactions6,9. In particular, PA26 
C termini form salt bridges with the pocket lysines. Thus, we sub-
stituted a residue in the A pocket that is proximal to the C termi-
nus of PA26. This residue is directly adjacent to the beginning of the 
A2 helix in each A subunit and is surface-exposed on the interior of 
the pocket (Fig. 1; for an alignment of A subunits in this region, see 
Supplementary Fig. 1b). We individually introduced cysteines into 
each A subunit. These A subunit mutants were then crossed to the 
rpt mutants to create a 6×7 array of double cysteine-substitution 
mutants. All double-mutant combinations were viable (Supplementary 






Figure 1 Structural basis for the cross-linking strategy. Detail of a 
representative A p ck t (A4-A5), showing residues sed for cross-linking. 
A surface representation of the A5 subunit is shown along with a cartoon 
representation of the last 12 residues of a PA26 subunit inserte  into the 
A4-A5 pock t9. A5 is in purple, with the pocket surface of this subunit 
in blue. A partial backbone of the A5 subunit is presented in cartoon 
mode, with the side chain of Thr82 (the residue substituted with cysteine 
and used for cross-linking) and Lys66 of the A5 subunit as well as the 
C-terminal carbonyl group of PA26 presented in stick mode. The distance 
between the C terminus of PA26 and the pocket lysine Lys66, as well as 
that between the C terminus and Thr82, are labeled (PDB: 1FNT11).
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Figure 2 Identification of two A-Rpt subunit pairs by cysteine cross-
linking. (a,b) Whole-cell lysates of yeast were subjected to cross-linking 
and SDS-PAGE–immunoblot analysis. In each panel, strains contain one 
A and one Rpt subunit with introduced cysteines. Panels a and b represent 
A1-I87C and A5-T82C mutants, respectively. Each panel contains a 
complete set of Rpt C-terminal mutants, as indicated (Rpt1-N467C, 
Rpt2-L437C, Rpt3-K428C, Rpt4-L437C, Rpt5-A434C and Rpt6-K405C). 
A 6×HA tag is present at the C terminus of each A subunit. BMOE (0.1 mM) 
is a cysteine-cysteine cross-linker; cross-linking proceeded for 1 h at 4 °C. 
Cross-linked products are marked by an arrow. The antibody used to 
probe each panel is indicated at bottom. The electrophoretic mobility 
and molecular mass (in kDa) of protein standards are indicated at left. 
(c–f) Purified proteasomes from wild-type yeast or mutant yeasts with 
either a single cysteine substitution or a double cysteine substitution 
within the two A-Rpt pairs identified in panels a and b were subjected to 
cross-linking and SDS-PAGE–immunoblot (IB) analysis. Panels c and e for 
A1–Rpt4; panel d and f for A5–Rpt1. Here, as below, proteasomes were 




Figure	  16	  	  Pba1p-­‐α6	  BMOE	  Crosslinking	  Under	  Non-­‐Reducing	  Conditions	  +	  MG132	  +	  Flag	  
Pull-­‐Down	  
Pba1p	  and	  α6	  were	  each	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  
come	  within	  close	  proximity	  of	  one	  another	  if	  the	  α5-­‐α6	  pocket	  is	  the	  correct	  binding	  
site	  for	  Pba1p.	  Prior	  to	  crosslinking,	  the	  samples	  were	  incubated	  in	  proteasome	  inhibitor	  
MG132.	  	  Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  from	  50	  ml	  
cultures	  in	  BMOE	  for	  60	  minutes.	  	  Total	  fractions	  (20	  µl)	  of	  the	  lysate	  were	  collected	  (T),	  
and	  the	  remaining	  lysate	  was	  incubated	  in	  M2	  Flag	  resin.	  	  The	  flag-­‐tagged	  Pba1	  proteins	  
were	  eluted	  by	  boiling	  the	  resin	  in	  20	  µl	  sample	  buffer	  (E).	  	  After	  non-­‐reducing	  SDS-­‐PAGE	  
(10%),	  the	  crosslinking	  was	  visualized	  by	  anti-­‐HA	  immunoblotting.	  	  Within	  the	  eluate	  
lane	  containing	  crosslinkable	  Pba1p	  (lane	  6),	  there	  are	  two	  specific	  bands.	  	  One	  band	  is	  
present	  at	  approximately	  30	  kDa	  corresponding	  to	  the	  α6-­‐HA	  species	  (lane	  6).	  	  The	  
second	  band	  is	  located	  at	  approximately	  60	  kDa	  (*)	  corresponding	  to	  the	  size	  of	  a	  
Pba1p-­‐α6	  crosslink	  (lane	  6).	  	  These	  bands	  are	  not	  detected	  in	  the	  wild-­‐type	  or	  empty	  
vector	  eluate	  lanes	  (2	  and	  4).	  	  Strains	  used	  were	  AKY689	  (lanes	  1	  and	  2),	  AKY690	  (lane	  3	  



























Figure	  17	  	  Pba1p-­‐α6	  BMOE	  Crosslinking	  Under	  Reducing	  Conditions	  +	  MG132	  +	  Flag	  Pull-­‐
Down	  
Pba1p	  and	  α6	  were	  each	  engineered	  with	  cysteine	  residues	  (C).	  	  These	  cysteines	  will	  
come	  within	  close	  proximity	  of	  one	  another	  if	  the	  α5-­‐α6	  pocket	  is	  the	  correct	  binding	  
site	  for	  Pba1p.	  Prior	  to	  crosslinking,	  the	  samples	  were	  incubated	  in	  proteasome	  inhibitor	  
MG132.	  	  In	  all	  of	  the	  preceding	  representative	  blots,	  the	  method	  of	  lysis	  was	  
spheroplasting,	  however	  the	  cells	  in	  this	  experiment	  were	  lysed	  by	  bead	  beating.	  	  
Disulfide	  crosslinking	  was	  induced	  by	  incubating	  whole	  cell	  lysate	  from	  50	  ml	  cultures	  in	  
BMOE	  for	  60	  minutes.	  	  Total	  fractions	  (20	  µl)	  of	  the	  lysate	  were	  collected	  (T),	  and	  the	  
remaining	  lysate	  was	  incubated	  in	  M2	  Flag	  resin.	  	  The	  flag-­‐tagged	  Pba1	  proteins	  were	  
eluted	  by	  boiling	  the	  resin	  in	  20	  µl	  sample	  buffer	  (E).	  	  After	  reducing	  SDS-­‐PAGE	  (10%),	  
the	  crosslinking	  was	  visualized	  by	  anti-­‐HA	  immunoblotting.	  	  Within	  the	  Pba1p	  wild-­‐type	  
and	  crosslinkable	  eluate	  lanes	  (4	  and	  6)	  there	  is	  a	  band	  present	  at	  approximately	  30	  kDa	  
corresponding	  to	  the	  α6-­‐HA	  species.	  	  This	  band	  is	  not	  observed	  in	  the	  empty	  vector	  
eluate	  lane	  (2).	  	  The	  Pba1p-­‐α6	  crosslink	  was	  expected	  in	  lane	  6	  at	  approximately	  60	  kDa	  
(position	  denoted	  with	  an	  *);	  however,	  no	  such	  band	  was	  observed.	  	  Strains	  used	  were	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